{"stringID": "pubmed_000000", "n_questions": 9, "n_agree": 0, "n_disagree": 9, "askqe_score": 0.0}
{"stringID": "pubmed_000001", "n_questions": 10, "n_agree": 5, "n_disagree": 5, "askqe_score": 0.5}
{"stringID": "pubmed_000002", "n_questions": 9, "n_agree": 3, "n_disagree": 6, "askqe_score": 0.3333333333333333}
{"stringID": "pubmed_000003", "qa_pairs": [{"question": "1. Which agricultural pests belong to the Lepidoptera order and negatively impact stored grains and food and fiber crops?", "answer_source": "The text states that Lepidoptera include agricultural pests that negatively affect stored grains and food and fiber crops. Therefore, the answer is: Lepidoptera agricultural pests.", "answer_summary": "Many Lepidopteran insects are agricultural pests that affect stored grains, food and fiber crops. (text)", "agree": true}, {"question": "2. Approximately how many eggs can a single adult lepidopteran insect produce?", "answer_source": "A single adult lepidopteran insect can produce hundreds of eggs.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of eggs a single adult lepidopteran insect produces.", "agree": false}, {"question": "3. What is the primary food source for lepidopteran insects?", "answer_source": "The primary food source for lepidopteran insects is plant material.", "answer_summary": "NOT_FOUND. The text does not provide information about the primary food source for lepidopteran insects.", "agree": false}, {"question": "4. How can biological agents be used to manage lepidoptera insect pests?", "answer_source": "Biological agents can be used to manage lepidoptera insect pests.  Question: 5. What is the primary food source of lepidoptera adults?  Answer:  The primary food source of lepidoptera adults is plant material.  Question: 6. What", "answer_summary": "Understanding and targeting the expression of antimicrobial peptides (AMPs) in lepidopteran insects can aid in the development of specific insect pest management compounds. These peptides disrupt microbial membranes, promoting pathogen clearance and insect survival. While the general", "agree": false}, {"question": "5. In what ways can insecticides impact the natural ecosystems and yields of crops that rely on pollination?", "answer_source": "Insecticides can disrupt natural ecosystems and reduce yields of crops that rely on pollination by affecting non-target organisms, including pollinators.", "answer_summary": "NOT_FOUND. The text does not provide information on how insecticides impact the natural ecosystems and yields of crops that rely on pollination.", "agree": false}, {"question": "6. Which cellular immune responses in insects can be affected by certain pesticides?", "answer_source": "The text mentions that currently used pesticides have been shown to affect cellular immune responses in insects (710). Therefore, the answer is:  Cellular immune responses.", "answer_summary": "NOT_FOUND.  The text does not mention any specific cellular immune responses in insects that can be affected by pesticides.", "agree": false}, {"question": "7. How do some pesticides interfere with grooming behavior in insects?", "answer_source": "The text does not explicitly state how some pesticides interfere with grooming behavior in insects. Therefore, NOT_FOUND.", "answer_summary": "NOT_FOUND. The text does not mention anything about pesticides interfering with grooming behavior in insects.", "agree": true}, {"question": "8. Which humoral immune responses in insects can be affected by currently used pesticides?", "answer_source": "The text mentions that currently used pesticides can affect humoral immune responses in insects, but it does not specify which humoral immune responses are affected.  Answer: NOT_FOUND (for a specific humoral immune response)  However, if you're asking which humoral immune", "answer_summary": "NOT_FOUND.  The text does not mention any specific humoral immune responses in insects that can be affected by currently used pesticides.", "agree": false}, {"question": "9. In the context of insect control, what is the significance of immune pathways as candidate molecules?", "answer_source": "The text mentions that currently used pesticides can affect both cellular and humoral immune responses in insects (7, 11, 12). However, it does not explicitly state the significance of immune pathways as candidate molecules in insect control.  Answer: NOT_FOUND", "answer_summary": "Immune pathways, specifically those leading to antimicrobial peptide (AMP) expression, are significant in insect control as they represent logical targets for the development of specific insect pest management compounds. These peptides disrupt microbial membranes, promoting pathogen clearance and insect survival.", "agree": false}, {"question": "10. How are fundamental mechanisms of innate immunity conserved throughout the animal kingdom?", "answer_source": "NOT_FOUND. The text does not provide information on how fundamental mechanisms of innate immunity are conserved throughout the animal kingdom.", "answer_summary": "The text states that the general pathways leading to antimicrobial peptide (AMP) expression, a fundamental aspect of innate immunity, are conserved between lepidopterans and dipterans.", "agree": false}, {"question": "11. In what ways do aspects of immune systems evolve in response to varying pathogen exposure and pathogen virulence determinants?", "answer_source": "NOT_FOUND. The text does not provide information on how aspects of immune systems evolve in response to varying pathogen exposure and pathogen virulence determinants for Lepidoptera or any other organisms.", "answer_summary": "NOT_FOUND. The text does not provide information on how aspects of immune systems evolve in response to varying pathogen exposure and pathogen virulence determinants specifically in the context of lepidopteran insects.", "agree": true}]}
{"stringID": "pubmed_000004", "qa_pairs": [{"question": "1. What physiological process results in the loss of consciousness during a syncope episode?", "answer_source": "Transient diffuse cerebral hypoperfusion.", "answer_summary": "The text suggests that decreased cerebral blood flow causes syncope in this case. Therefore, the answer is:  Decreased cerebral blood flow causing syncope.", "agree": false}, {"question": "2. Which symptoms are commonly associated with syncope episodes besides loss of consciousness?", "answer_source": "Myoclonic jerks, convulsions, and urinary incontinence.", "answer_summary": "Myoclonic jerks in extremities.", "agree": false}, {"question": "3. How does autoregulation of cerebral circulation prevent significant fluctuations in cerebral perfusion pressure?", "answer_source": "Autoregulation of cerebral circulation prevents significant fluctuations in cerebral perfusion pressure by maintaining a relatively constant cerebral blood flow despite changes in perfusion pressure.", "answer_summary": "NOT_FOUND. The text does not discuss autoregulation of cerebral circulation.", "agree": false}, {"question": "4. What condition may lead to cough syncope due to transient failure of the cerebral autoregulatory mechanism?", "answer_source": "Cough syncope is a condition where coughing leads to syncope (transient loss of consciousness) due to transient failure of the cerebral autoregulatory mechanism to cope with sudden decrease in cerebral blood flow.", "answer_summary": "Increased intracranial pressure due to glomus jugulare tumor or other factors.", "agree": false}, {"question": "5. In what part of the body was a 43-year-old woman diagnosed with a glomus jugulare tumor?", "answer_source": "The 43-year-old woman was diagnosed with a glomus jugulare tumor in the left jugular fossa.", "answer_summary": "The 43-year-old woman was diagnosed with a glomus jugulare tumor in the body. More specifically, it was located in the left side of her body.", "agree": true}, {"question": "6. How frequently did the patient experience syncope episodes during wakeful state?", "answer_source": "NOT_FOUND. The text does not provide information on the frequency of syncope episodes for the patient.", "answer_summary": "NOT_FOUND. The text does not provide information on the frequency of the patient's syncope episodes during wakeful state.", "agree": true}, {"question": "7. Which specific antiepileptic drugs was the patient taking at the time of presentation?", "answer_source": "NOT_FOUND. The text does not provide information about the specific antiepileptic drugs the patient was taking at the time of presentation.", "answer_summary": "NOT_FOUND. The text does not mention any specific antiepileptic drugs the patient was taking at the time of presentation.", "agree": true}]}
{"stringID": "pubmed_000005", "qa_pairs": [{"question": "1. What percentage of men in the general population experience male infertility?", "answer_source": "1 out of 20 men in the general population experience male infertility.  Question: 2. What percentage of infertility cases are caused by male factors?  Answer:  About 15% of infertility cases are caused by male factors.  Question:", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of men in the general population who experience male infertility.", "agree": false}, {"question": "2. Which specific conditions are known to cause male infertility: obstruction of deferent duct, varicocele, sexual dysfunction, and cryptorchidism?", "answer_source": "Obstruction of deferent duct, varicocele, sexual dysfunction, and cryptorchidism are conditions known to cause male infertility. (Text)", "answer_summary": "NOT_FOUND. The text only mentions non-obstructive azoospermia (NOA) and hypospermatogenesis as conditions related to male infertility in this study.", "agree": false}, {"question": "3. How has assisted reproductive technology (ART) contributed to the conception of sterile couples?", "answer_source": "Assisted reproductive technology (ART) has helped many sterile couples to conceive.  Question: 4. What is the proportion of male infertility cases caused by male factors?  Answer:  About 15% of male infertility cases are caused by male factors.", "answer_summary": "NOT_FOUND. The text does not provide information about assisted reproductive technology (ART) and its contribution to the conception of sterile couples.", "agree": false}, {"question": "4. What is the etiological mechanism behind non-obstructive azoospermia (NOA)?", "answer_source": "The etiological mechanism behind non-obstructive azoospermia (NOA) is unknown. However, factors such as oxidative stress have been considered to have effects on spermatogenesis.", "answer_summary": "NOT_FOUND. The text does not provide information on the etiological mechanism behind non-obstructive azoospermia (NOA). It only mentions that mir-210 is involved in spermatogenesis by targeting igf2 in male infertility, including NO", "agree": false}, {"question": "5. In what way is oxidative stress related to NOA?", "answer_source": "Oxidative stress is considered to have effects on spermatogenesis in the context of NOA, but the exact relationship is not explicitly stated in the text.", "answer_summary": "NOT_FOUND. The text does not provide information on oxidative stress and NOA (non-obstructive azoospermia) in relation to each other.", "agree": false}, {"question": "6. How do microRNAs regulate gene expression after transcription in the context of NOA?", "answer_source": "MicroRNAs regulate gene expression after transcription in the context of NOA by playing fundamental roles in regulating gene expression. Specifically, Lian et al. found 154 down-regulated miRNAs and 19 up-regulated miRNas in the context of", "answer_summary": "The text does not provide information on how microRNAs regulate gene expression after transcription specifically in the context of NOA beyond the fact that mir-210 targets igf2 in nt2 cells.  Question: 7. What is the role of mir-210 in s", "agree": false}, {"question": "7. According to the study by Lian et al., which microRNAs were found to be down-regulated and which were up-regulated in the testes of NOA patients?", "answer_source": "The study by Lian et al. found 154 down-regulated microRNAs and 19 up-regulated microRNAS in the testes of NOA patients.", "answer_summary": "The study found that mir-210 was significantly up-regulated (p<0.05) in the testes of NOA patients, while igf2 was down-regulated, but without a significant difference.", "agree": false}, {"question": "8. What was the primary objective of the study by Lian et al. regarding the role of mir-210 in the pathogenesis of spermatogenesis?", "answer_source": "NOT_FOUND. The text does mention the study by Lian et al. and that they found down-regulated and up-regulated miRNAs in testicular tissues, but it does not specify the primary objective of the study regarding the role of miR-210.", "answer_summary": "The primary objective of the study by Lian et al. was to investigate the role of mir-210 in the pathogenesis of spermatogenesis in patients with non-obstructive azoospermia (NOA).", "agree": false}, {"question": "9. How many patients with azoospermia were included in the study by Lian et al.?", "answer_source": "NOT_FOUND. The text does not provide information on the number of patients with azoospermia included in the study by Lian et al.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of patients included in the study by Lian et al.", "agree": true}]}
{"stringID": "pubmed_000006", "qa_pairs": [{"question": "1. What percentage of low-risk pregnant women in Japan requested midwife-led primary delivery care between 2009 and 2012?", "answer_source": "NOT_FOUND. The text does not provide information on the percentage of low-risk pregnant women in Japan who requested midwife-led primary delivery care between 2009 and 2012.", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of low-risk pregnant women in Japan who requested midwife-led primary delivery care between 2009 and 2012.", "agree": true}, {"question": "2. Which interventions are not available in midwife-led deliveries managed by independent midwives in Japan?", "answer_source": "NOT_FOUND. The text mentions a decrease in unnecessary medical interventions with midwife-led primary delivery care, but it does not specify which interventions are not available in midwife-led deliveries managed by independent midwives in Japan.", "answer_summary": "NOT_FOUND. The text does not provide information on which interventions are not available in midwife-led deliveries managed by independent midwives in Japan.", "agree": true}, {"question": "3. How many low-risk women started labor using midwife-led primary delivery care at 37 weeks of gestation or later between 2009 and 2012?", "answer_source": "NOT_FOUND. The text does not provide information on the number of low-risk women who started labor using midwife-led primary delivery care at 37 weeks of gestation or later between 2009 and 2012.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of low-risk women who started labor using midwife-led primary delivery care at 37 weeks of gestation or later between 2009 and 2012.", "agree": true}, {"question": "4. What percentage of these women intended to give birth at home?", "answer_source": "NOT_FOUND. The text mentions midwife-led primary delivery care in a hospital or neighboring hospital setting. No information is provided about giving birth at home.", "answer_summary": "NOT_FOUND. The text does not provide the percentage of women who intended to give birth at home.", "agree": false}, {"question": "5. In what year was the ethics committee approval for the study obtained at the Japanese Red Cross Katsushika Maternity Hospital?", "answer_source": "NOT_FOUND. The text does not provide the year the ethics committee approval was obtained at the Japanese Red Cross Katsushika Maternity Hospital.", "answer_summary": "NOT_FOUND. The text does not provide information about the year the ethics committee approval was obtained.", "agree": true}, {"question": "6. How can pregnant women in the hospital choose between midwife-led care and obstetric shared care?", "answer_source": "NOT_FOUND. The text does not provide information on how pregnant women in the hospital can choose between midwife-led care and obstetric shared care.", "answer_summary": "NOT_FOUND. The text does not provide information on how pregnant women in the hospital can choose between midwife-led care and obstetric shared care.", "agree": true}, {"question": "7. What level of autonomy do midwives in midwife-led care units have in their practice?", "answer_source": "Midwives in midwife-led care units have autonomy in primary delivery care for low-risk pregnant women, but they may need to refer women to obstetricians if complications occur or threaten to occur. (Text)", "answer_summary": "NOT_FOUND. The text does not provide information on the level of autonomy midwives in midwife-led care units have in their practice.", "agree": false}, {"question": "8. What percentage of low-risk women receiving midwife-led primary delivery care in Japan experienced complications requiring referral to obstetricians?", "answer_source": "NOT_FOUND. The text does not provide information on the percentage of low-risk women experiencing complications requiring referral to obstetricians during midwife-led primary delivery care in Japan.", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of low-risk women experiencing complications requiring referral to obstetricians in any of the three systems of midwife-led primary delivery care.", "agree": true}]}
{"stringID": "pubmed_000007", "qa_pairs": [{"question": "1. Which genetic determinants, specifically common variants of which genes (adrb3, pparg, enpp1, and capn10), have been investigated for their association with the development of type 2 diabetes?", "answer_source": "The common variants of the genes adrb3, pparg, enpp1, and capn10 have been investigated for their association with the development of type 2 diabetes.", "answer_summary": "The text specifically mentions that the enpp1 gene and its k121q polymorphism have been investigated for their association with type 2 diabetes. No mention is made of the other genes (adrb3, pparg, and capn10) in the context of this study.", "agree": false}, {"question": "2. How is type 2 diabetes characterized at the biochemical level, and what role does insulin resistance play in this condition?", "answer_source": "Type 2 diabetes is characterized by insulin resistance (6). Enpp1, a gene associated with insulin resistance, interacts with the insulin receptor to interrupt signaling (7, 9). However, the k121q polymorphism of the human pc-1 gene, which", "answer_summary": "Type 2 diabetes is characterized by insulin resistance. Insulin resistance is a biochemical condition where the body's cells do not respond properly to insulin, making it harder for glucose to enter the cells and be used for energy.", "agree": false}, {"question": "3. In what way does the enpp1 gene contribute to the development of insulin resistance?", "answer_source": "The enpp1 gene interacts with the insulin receptor's Î²-subunit to interrupt signaling, contributing to insulin resistance. (7, 8, 9)", "answer_summary": "NOT_FOUND. The text explains that the enpp1 gene plays a role in insulin resistance, but it does not provide information on how this role is contributed.", "agree": false}, {"question": "4. What is the relationship between the k121q polymorphism of the human pc-1 gene and insulin resistance, according to some studies?", "answer_source": "There were discrepancies in the findings of some studies regarding the association between the k121q polymorphism of the human pc-1 gene and insulin resistance. While some studies reported a strong association (1, 3, 7, 10-12), others found no association", "answer_summary": "The text states that ENPP1 plays a role in insulin resistance, but it does not provide specific information about the relationship between the k121q polymorphism and insulin resistance. Therefore, NOT_FOUND.", "agree": false}, {"question": "5. According to other studies, is there no association between the k121q variant and insulin resistance?", "answer_source": "Yes, according to studies mentioned in the text, there was no association between insulin resistance and the k121q variant.", "answer_summary": "NOT_FOUND. The text only mentions the results of one specific study regarding the association between the k121q variant and insulin resistance in Korean males. It does not provide information about other studies on this topic.", "agree": false}, {"question": "6. What discrepancies exist regarding the impact of the enpp1 polymorphism on obesity between different ethnic groups?", "answer_source": "The text mentions discrepancies for the impact of enpp1 polymorphism on obesity between ethnic groups (5, 10, 13, 15-19). Therefore, the answer is: DISCREPANCIES.", "answer_summary": "NOT_FOUND. The text only mentions the results of a study in Korean male workers and does not provide any information about the impact of the enpp1 polymorphism on obesity in other ethnic groups.", "agree": false}, {"question": "7. Given that the research subject has a BMI of 23, how does the three-allele risk type haploid qdeltg, specifically the q allele, affect the risk for obesity?", "answer_source": "NOT_FOUND.  The text does not provide information on the relationship between the q allele of the three-allele risk type haploid qdeltg and the risk for obesity for individuals with a BMI of 23.", "answer_summary": "NOT_FOUND.  The text does not provide information on how the three-allele risk type haploid qdeltg, specifically the q allele, affects the risk for obesity in individuals with a BMI of 23.", "agree": true}]}
{"stringID": "pubmed_000008", "qa_pairs": [{"question": "1. What is the effectiveness of lipid apheresis in treating severe hyperlipidemia, according to the study?", "answer_source": "Lipid apheresis is effective in treating severe hyperlipidemia, as stated in the text.  Question: 2. How does lipid apheresis function to remove LDL from the blood?  Answer: Lipid apheresis functions by separating plasma from", "answer_summary": "The study reports significant reductions in mean total cholesterol (58.4%), LDL-c (71.9%), triglycerides (51%), HDL cholesterol (9.3%), and non-HDL (68.2%)", "agree": false}, {"question": "2. How does lipid apheresis separate plasma from blood cells using a cell separator?", "answer_source": "The text states that lipid apheresis separates plasma from blood cells using a cell separator, but it does not provide further details on how this process is accomplished. Therefore, the answer is: NOT_FOUND.", "answer_summary": "NOT_FOUND. The text does not provide information on how lipid apheresis separates plasma from blood cells using a cell separator.", "agree": false}, {"question": "3. Which types of affinity columns are used in lipid apheresis for lipid removal?", "answer_source": "Affinity columns containing anti-apolipoprotein B antibodies are used in lipid apheresis for lipid removal.", "answer_summary": "NOT_FOUND. The text does not provide information on the types of affinity columns used in lipid apheresis for lipid removal.", "agree": false}, {"question": "4. How do patients' LDL levels compare to traditional drug therapy alone after undergoing lipid apheresis?", "answer_source": "Patients' LDL levels are lower after undergoing lipid apheresis than with traditional drug therapy alone.", "answer_summary": "The text states that there was a 71.9% reduction in LDL-c levels after lipid apheresis. This is a greater reduction than what can typically be achieved with traditional drug therapy alone.", "agree": false}, {"question": "5. Are HDL levels affected by lipid apheresis?", "answer_source": "NOT_FOUND. The text states that HDL levels are generally unaffected by lipid apheresis.", "answer_summary": "Yes, HDL levels were reduced by 9.3% on average after lipid apheresis.", "agree": false}, {"question": "6. How does lipid apheresis contribute to the regression of coronary atherosclerotic plaque in FH patients when used with statins?", "answer_source": "NOT_FOUND (The text states that lipid apheresis induces the regression of coronary atherosclerotic plaque in FH patients when used with statins, but it does not provide information on how it contributes to this effect.)", "answer_summary": "NOT_FOUND. The text does not provide information on how lipid apheresis contributes to the regression of coronary atherosclerotic plaque in FH patients when used with statins.", "agree": true}, {"question": "7. What is the incidence of FH in the general population?", "answer_source": "The incidence of FH in the general population is about 1 in 500 persons.", "answer_summary": "NOT_FOUND. The text does not provide information on the incidence of FH in the general population.", "agree": false}, {"question": "8. What health complications are associated with FH?", "answer_source": "An increased risk for atherosclerosis and premature coronary heart disease.", "answer_summary": "The text mentions that 10 out of 11 patients undergoing lipid apheresis have a diagnosis of FH (Familial Hypercholesterolemia). However, the text does not provide information on the specific health complications associated with FH.  Answer:", "agree": false}, {"question": "9. Which genes are implicated in FH and how do mutations affect LDL metabolism?", "answer_source": "NOT_FOUND. The text mentions that FH is a group of autosomal dominant genetic defects, but it does not specify which genes are implicated. The text also mentions that mutations result in elevated LDL cholesterol levels, but it does not provide details on how", "answer_summary": "NOT_FOUND. The text does not provide information on the specific genes implicated in FH (Familial Hypercholesterolemia) or how mutations affect LDL (Low-Density Lipoprotein) metabolism.", "agree": false}, {"question": "10. In which hospitals was the study on lipid apheresis for hyperlipidemia conducted?", "answer_source": "NOT_FOUND. The text does not provide information on where the study on lipid apheresis for hyperlipidemia was conducted.", "answer_summary": "NOT_FOUND. The text does not provide information on the hospitals where the study was conducted.", "agree": true}, {"question": "11. How were patients identified for the study at Allina Health?", "answer_source": "NOT_FOUND. The text does not provide information on how patients were identified for the study at Allina Health.", "answer_summary": "An electronic health record screen identified 11 active patients undergoing lipid apheresis.", "agree": false}]}
{"stringID": "pubmed_000009", "qa_pairs": [{"question": "1. What is the history of skin ulcers on the right calf of the given person?", "answer_source": "The person had been experiencing recurrent episodes of deep vein thrombosis (DVT) in the right leg for 15 years, which resulted in cellulitis on one occasion.  Question: 2. What is the age of the person with recurrent DVT and agenesis of", "answer_summary": "The given person is a 33-year-old male who had experienced multiple recurrent episodes of deep vein thrombosis (DVT) over a 15-year period, leading to cellulitis in the right leg.  Question: 2. What is the cause of the", "agree": false}, {"question": "2. How long have recurrent deep vein thrombosis episodes occurred in the right leg of the 33-year-old male?", "answer_source": "The recurrent deep vein thrombosis episodes in the right leg of the 33-year-old male have occurred for 15 years.", "answer_summary": "The recurrent deep vein thrombosis episodes in the right leg of the 33-year-old male have occurred over a 15-year period.", "agree": true}, {"question": "3. What is the risk factor for deep vein thrombosis in young individuals, apart from the recurrent episodes in the given patient?", "answer_source": "Congenital anomalies of the inferior vena cava (IVC).", "answer_summary": "Congenital absence of the inferior vena cava.", "agree": true}, {"question": "4. What medications was the patient taking before being admitted to the hospital for cellulitis in the right leg?", "answer_source": "NOT_FOUND. The text does not provide information about the medications the patient was taking before being admitted to the hospital.", "answer_summary": "NOT_FOUND. The text does not provide information about the medications the patient was taking before being admitted to the hospital for cellulitis in the right leg.", "agree": true}, {"question": "5. What investigations have been conducted to diagnose a primary hypercoagulability state in the patient, and what were the results?", "answer_source": "NOT_FOUND. The text does not provide information on investigations conducted or results for a primary hypercoagulability state in the patient.", "answer_summary": "The text does not provide information on investigations conducted to diagnose a primary hypercoagulability state in the patient or the results of those investigations. The text only mentions the patient's history of recurrent deep vein thrombosis and the discovery of an absent inferior vena cava during", "agree": false}, {"question": "6. What are the symptoms of swelling, edema, redness, increased temperature, and trophic skin changes in the right ankle and calf of the patient?", "answer_source": "The patient experienced symptoms of cellulitis in the right leg, including swelling, edema, redness, increased temperature, and trophic skin changes.", "answer_summary": "The patient presented with symptoms of cellulitis in the right leg, including swelling, edema, redness, increased temperature, and trophic skin changes.", "agree": true}, {"question": "7. Are there any visible varicose veins in the lower abdomen of the patient?", "answer_source": "NOT_FOUND. The text does not mention anything about varicose veins in the lower abdomen of the patient.", "answer_summary": "NOT_FOUND. The text does not mention anything about varicose veins in the lower abdomen of the patient.", "agree": true}]}
{"stringID": "pubmed_000010", "qa_pairs": [{"question": "1. What is the predicted rate of increase in Alzheimer's disease (AD) prevalence due to aging baby boomers?", "answer_source": "An exponential rise is predicted.  Question: 2. What could be the potential economic impact of Alzheimer's disease (AD) if earlier pharmacological intervention is not implemented?  Answer:  It could create an unsustainable economic burden to the healthcare system.  Question", "answer_summary": "NOT_FOUND. The text does not provide information on the predicted rate of increase in Alzheimer's disease (AD) prevalence due to aging baby boomers.", "agree": false}, {"question": "2. How could delaying the onset or progression of AD through earlier pharmacological intervention reduce economic and psychosocial impact?", "answer_source": "Delaying the onset or progression of AD through earlier pharmacological intervention could reduce economic and psychosocial impact by decreasing the number of individuals requiring costly healthcare services and support during the later stages of the disease. (Reference(s): 1, 2)", "answer_summary": "NOT_FOUND. The text does not provide information on the economic and psychosocial impact of delaying the onset or progression of AD through earlier pharmacological intervention.", "agree": false}, {"question": "3. What percentage of AD patients remain undiagnosed or go undetected until later stages?", "answer_source": "NOT_FOUND. The text does not provide a percentage for the number of AD patients who remain undiagnosed or go undetected until later stages.", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of AD patients who remain undiagnosed or go undetected until later stages.", "agree": true}, {"question": "4. How have insights into beta-amyloid plaque deposition contributed to the development of antiamyloid agents?", "answer_source": "Insights into beta-amyloid plaque deposition within the brain have led to the development of antiamyloid agents.", "answer_summary": "NOT_FOUND.  The text discusses the use of serum A beta levels and neuropsychological tests for predicting MCI and AD, but it does not provide information on how insights into beta-amyloid plaque deposition have contributed to the development of antiamyloid agents", "agree": false}, {"question": "5. When do pathological events in AD typically initiate in relation to clinical symptoms?", "answer_source": "Pathological events in AD initiate decades before clinical symptoms become apparent.", "answer_summary": "NOT_FOUND. The text does not provide information on when pathological events in AD typically initiate in relation to clinical symptoms.", "agree": false}, {"question": "6. Which neuropsychological measures, particularly those tapping hippocampal formation, have been useful in identifying cognitively normal elders who develop AD?", "answer_source": "NOT_FOUND.  The text mentions that many AD patients remain undiagnosed until the later stages of the disease and that neuropsychological measures, particularly those tapping cognitive abilities subsumed by the hippocampal formation, have been useful. However, it does not provide specific", "answer_summary": "NOT_FOUND. The text mentions that baseline measures of global cognition, memory, and language fluency were significant predictors for future MCI/AD, but it does not specify which neuropsychological tests, if any, tap the hippocampal formation in particular.", "agree": false}, {"question": "7. What decadal difference in cognitive decline is observed in individuals prior to the development of Alzheimer's disease?", "answer_source": "The text states that the pathological events in Alzheimer's disease (AD) initiate decades before clinical symptoms become apparent. However, it does not provide an exact decadal difference in cognitive decline.  Answer: NOT_FOUND.", "answer_summary": "NOT_FOUND. The text does not provide information on the decadal difference in cognitive decline prior to the development of Alzheimer's disease.", "agree": false}, {"question": "8. How do performance on visual-spatial and verbal memory measures in midlife predict later memory loss?", "answer_source": "NOT_FOUND. The text mentions neuropsychological measures and their relationship to memory loss in later life, but it does not specifically discuss the predictive value of performance on visual-spatial and verbal memory measures in midlife for later memory loss.", "answer_summary": "NOT_FOUND. The text mentions the use of neuropsychological tests for predicting memory loss in older adults, but it does not specifically mention visual-spatial and verbal memory measures or their predictive relationship with later memory loss.", "agree": false}, {"question": "9. In individuals with high premorbid intellectual abilities, how often may incipient cognitive decline go undetected?", "answer_source": "NOT_FOUND.  The text does mention that many Alzheimer's disease (AD) patients remain undetected until the later stages of the disease, but it does not provide information on how often this occurs in individuals with high premorbid intellectual abilities.", "answer_summary": "NOT_FOUND. The text does not provide information on the frequency of undetected cognitive decline in individuals with high premorbid intellectual abilities.", "agree": false}]}
{"stringID": "pubmed_000012", "qa_pairs": [{"question": "1. What gene is identified as a transcriptional target of nuclear -catenin in the context of the Wnt/-catenin pathway?", "answer_source": "The genes identified as transcriptional targets of nuclear -catenin in the context of the Wnt/-catenin pathway include cyclin d1, c-myc, and the melanocyte-specific gene, microphthalmia-associated transcription factor MITF-M", "answer_summary": "NOT_FOUND. The text does not provide information on the specific gene identified as a transcriptional target of nuclear -catenin in the context of the Wnt/-catenin pathway.", "agree": false}, {"question": "2. How is the expression of the Rad6 gene influenced by nuclear -catenin?", "answer_source": "NOT_FOUND. The text does not mention the Rad6 gene in relation to nuclear -catenin.", "answer_summary": "NOT_FOUND. The text does not provide information on how the expression of the Rad6 gene is influenced by nuclear -catenin.", "agree": true}, {"question": "3. In which types of breast tissues is the expression of Rad6 protein typically low?", "answer_source": "NOT_FOUND. The text does not mention Rad6 protein.", "answer_summary": "NOT_FOUND. The text does not mention the expression of Rad6 protein in breast tissues.", "agree": true}, {"question": "4. In which stages of breast carcinoma is an increase in Rad6 protein expression detected?", "answer_source": "NOT_FOUND. The text does not mention Rad6 protein expression in breast carcinoma.", "answer_summary": "NOT_FOUND. The text does not provide information about Rad6 protein expression in breast carcinoma.", "agree": true}, {"question": "5. What role does Rad6 play in breast cancer progression through its interaction with the canonical Wnt/-catenin pathway?", "answer_source": "NOT_FOUND. The text does not mention Rad6 and its role in breast cancer progression through its interaction with the canonical Wnt/-catenin pathway.", "answer_summary": "Rad6 enhances breast cancer development and progression through a positive feedback loop with -catenin. (Text)  Question: 6. In which types of melanomas was strong expression of Rad6 observed?  Answer:  Rad6 was strongly expressed in only 27% of", "agree": false}, {"question": "6. What is the relationship between decreased or lost nuclear -catenin expression and melanoma progression?", "answer_source": "NOT_FOUND. The text states that nuclear -catenin accumulation is a marker of poor prognosis in melanoma, not decreased or lost expression.", "answer_summary": "NOT_FOUND. The text does not provide information on the relationship between decreased or lost nuclear -catenin expression and melanoma progression.", "agree": false}]}
{"stringID": "pubmed_000013", "qa_pairs": [{"question": "1. Which part of the guanine heterocyclic ring is most reactive toward oxidants and adduct-forming species?", "answer_source": "The part of the guanine heterocyclic ring that is most reactive toward oxidants and adduct-forming species is 2-deoxyguanosine (dG), specifically at the c5 position.", "answer_summary": "NOT_FOUND.  The text mentions that the initial electrophilic intermediate of 2-deoxyguanosine (dg) upon oxidation displays a wide range of reactivities with nucleophiles, leading to many downstream products. However, it does not specify which part", "agree": false}, {"question": "2. Where is the primary site of base oxidation in DNA when using one-electron oxidants?", "answer_source": "The primary site of base oxidation in DNA using one-electron oxidants is at the 2-deoxyguanosine (dG) with a low redox potential.", "answer_summary": "NOT_FOUND. The text describes the oxidation of 2-deoxyguanosine (dG) specifically, and does not mention the primary site of base oxidation in DNA in general using one-electron oxidants.", "agree": false}, {"question": "3. How can the principal products of one-electron oxidants in aqueous solutions be categorized based on the site of reaction on the radical intermediate?", "answer_source": "The principal products of one-electron oxidants in aqueous solutions can be categorized based on the site of reaction on the radical intermediate, specifically on the 2-deoxyguanosine (dG) nucleoside. The products arising from initial reactivity at c5 of dG", "answer_summary": "Based on the text, the principal products of one-electron oxidants in aqueous solutions can be categorized as spiroiminodihydantoin, 5-guanidinohydantoin, oxazolone, and diastereotopic constitutional isomers with", "agree": false}, {"question": "4. Which specific 2-deoxyribonucleoside products result from initial reactivity at c5 of 2-deoxyguanosine (dG)?", "answer_source": "A four-electron oxidation product, an imidazolone (diz, m-39), an oxazolone (dz, m-21), and the two-electron oxidation product 5-carboxamido-5-formamido-2-", "answer_summary": "The text identifies the 2-deoxyribonucleoside products of spiroiminodihydantoin that result from initial reactivity at c5 of 2-deoxyguanosine (dG) when water is the nucleophile.", "agree": false}, {"question": "5. What are the products observed when the initial reaction occurs at c8 of dG under reducing conditions?", "answer_source": "2,6-diamino-4-hydroxy-5-formamidopyrimidine (fapy-dG, m + 18)", "answer_summary": "NOT_FOUND. The text mentions the observation of products with substitution of either the c5 or c8 carbonyl of dG with an amine when using ammonia as a nucleophile, but it does not specify which carbon the amine is attached to in the case of c8", "agree": false}, {"question": "6. What nucleophilic participants, other than water, can participate in oxidation reactions with dG in a cellular context?", "answer_source": "NOT_FOUND.  The text mentions the participation of one-electron oxidants in the oxidation of dG, but it does not specify any nucleophilic participants other than water in the given reactions.", "answer_summary": "NH3.  Question: 7. What are the structures of the NH3 adducts formed during the oxidation of dG?  Answer:  Spirocycles with substitution of either the c5 or c8 carbonyl with an amine.", "agree": false}, {"question": "7. What is the structure of the lysine adduct observed at c8 in lysine adducts, analogous to dG?", "answer_source": "NOT_FOUND. The text provides information about the structures and mass signatures of various products resulting from the oxidation of 2-deoxyguanosine (dG) at different sites, but it does not mention anything about lysine adducts or their structures.", "answer_summary": "NOT_FOUND. The text mentions lysine adducts with characteristic masses of dG + 31, but it does not provide information about the structure of the adducts at the c8 position.", "agree": false}, {"question": "8. Where is a lysine adduct observed in a spirocyclic core similar to dsp?", "answer_source": "NOT_FOUND. The text does not mention anything about a lysine adduct or a spirocyclic core similar to dsp.", "answer_summary": "NOT_FOUND. The text mentions spirocycles with substitution of either the c5 or c8 carbonyl with an amine as NH3 adducts, but it does not mention lysine or a lysine adduct.", "agree": false}]}
{"stringID": "pubmed_000014", "qa_pairs": [{"question": "1. What was the initial finding in the semen analysis of the 32-year-old male patient regarding his sperm motility?", "answer_source": "The initial finding in the semen analysis of the 32-year-old male patient regarding his sperm motility was NOT_FOUND as the text does not provide that information.", "answer_summary": "The initial finding in the semen analysis of the 32-year-old male patient regarding his sperm motility was low.", "agree": true}, {"question": "2. Which medical conditions were ruled out in the patient's recent medical history through negative results in a military service physical exam and a screening exam for pulmonary tuberculosis?", "answer_source": "NOT_FOUND. The text does not provide information about which medical conditions were ruled out through negative results in the patient's military service physical exam and a screening exam for pulmonary tuberculosis. The text only mentions the patient's infertility and the use of guaifenesin", "answer_summary": "NOT_FOUND. The text does not provide information about any medical conditions ruled out through military service physical exam or a screening exam for pulmonary tuberculosis for the patient in question.", "agree": false}, {"question": "3. What was the patient's occupation and reported alcohol consumption before undergoing infertility evaluation?", "answer_source": "NOT_FOUND. The text does not provide information about the patient's occupation or reported alcohol consumption before undergoing infertility evaluation.", "answer_summary": "NOT_FOUND. The text does not provide information about the patient's occupation or reported alcohol consumption before undergoing infertility evaluation.", "agree": true}, {"question": "4. How long had the patient and his wife been trying to conceive unprotected before seeking medical help?", "answer_source": "The patient had been trying to conceive with his wife for 18 months.", "answer_summary": "The patient and his wife had been trying to conceive unprotected for 18 months.", "agree": true}, {"question": "5. Which CPT code was used for the patient's semen analysis during the infertility evaluation?", "answer_source": "NOT_FOUND. The text does not mention the CPT code used for the patient's semen analysis.", "answer_summary": "NOT_FOUND. The text does not provide information about the specific CPT code used for the patient's semen analysis.", "agree": true}, {"question": "6. What were the initial semen analysis results regarding the patient's total sperm count and motility?", "answer_source": "The initial semen analysis results regarding the patient's total sperm count and motility were not specified in the text.", "answer_summary": "The initial semen analysis demonstrated low sperm count and motility.", "agree": true}, {"question": "7. How were the semen samples collected and transported to the lab for analysis?", "answer_source": "NOT_FOUND. The text does not provide information on how the semen samples were collected and transported to the lab for analysis.", "answer_summary": "NOT_FOUND. The text does not provide information on how the semen samples were collected and transported to the lab for analysis.", "agree": true}, {"question": "8. What medication was prescribed to the patient for improving his sperm motility and for how long was he treated?", "answer_source": "The patient was prescribed guaifenesin for improving his sperm motility. He was treated for two months.", "answer_summary": "The patient was prescribed guaifenesin 600 mg extended release tablets twice daily for two months.", "agree": true}, {"question": "9. What improvements were observed in the patient's semen analysis after two months of guaifenesin therapy?", "answer_source": "The patient demonstrated marked improvement in both total sperm count and motility after two months of guaifenesin therapy.", "answer_summary": "Marked improvement in both total sperm count and motility.", "agree": true}]}
{"stringID": "pubmed_000015", "qa_pairs": [{"question": "1. What percentage of the Philippines' GDP does the agricultural sector contribute?", "answer_source": "The agricultural sector contributes about 20% to the Philippines' GDP.", "answer_summary": "NOT_FOUND.  Question: 2. What were the three most commonly used pesticides in the study?  Answer:  The three most commonly used pesticides were pyrethroid (46.4%), organophosphates (24.2%), and", "agree": false}, {"question": "2. How much did crops contribute to the national income of the Philippines in a specific year?", "answer_source": "In the text, it mentions that crops contributed about 510 billion pesos (p510b) to the national income of the Philippines, but it does not specify a particular year. Therefore, the answer is: 510 billion pesos (p510b).", "answer_summary": "NOT_FOUND. The text does not provide information about the national income of the Philippines, specifically in relation to crops.", "agree": false}, {"question": "3. In which province of the Philippines is there approximately 27,500 farms covering 30,000 hectares of agricultural land?", "answer_source": "Benguet", "answer_summary": "NOT_FOUND. The text does not provide information about the location of the 211 farms mentioned in the study.", "agree": false}, {"question": "4. Which crops does Benguet province produce the most in terms of percentage of the national output for broccoli and carrots?", "answer_source": "Benguet province contributes 87.4% to the national output of broccoli and 81.4% to the national output of carrots.", "answer_summary": "NOT_FOUND. The text does not provide information about the percentage of national output for broccoli and carrots produced in Benguet province.", "agree": false}, {"question": "5. What are the common health complaints reported by vegetable farmers in Benguet, Philippines?", "answer_source": "NOT_FOUND. The text mentions that growing vegetables is considered a risk occupation in some areas, but it does not provide information on specific health complaints reported by farmers in Benguet.", "answer_summary": "The common health complaints reported by vegetable farmers were headache (64.1%), muscle pain (61.1%), cough (45.5%), weakness (42.4%), eye pain (39.9%), chest pain (37.4%), and eye", "agree": false}, {"question": "6. In which time period did organophosphates cause the highest number of pesticide poisoning cases in the Philippines?", "answer_source": "NOT_FOUND. The text does not provide information on organophosphates or pesticide poisoning cases in the Philippines.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of pesticide poisoning cases caused by organophosphates or the time period in question.", "agree": true}, {"question": "7. Which class of pesticides caused the most number of pesticide poisoning deaths in the Philippines from 1991-1995?", "answer_source": "NOT_FOUND. The text does not provide information on pesticide poisoning deaths or the class of pesticides involved.", "answer_summary": "NOT_FOUND. The text does not provide information on pesticide poisoning deaths or the specific class of pesticides involved in such incidents in the Philippines during the given time frame.", "agree": true}, {"question": "8. Based on a 2000 study, what were the prevalence rates of acute and chronic pesticide poisoning among Benguet vegetable farmers?", "answer_source": "NOT_FOUND. The text does not provide information on the prevalence rates of acute and chronic pesticide poisoning among Benguet vegetable farmers in a 2000 study.", "answer_summary": "NOT_FOUND. The text does not provide information on the prevalence rates of acute and chronic pesticide poisoning among Benguet vegetable farmers.", "agree": true}, {"question": "9. What was the aim of the 2001 study regarding pesticide exposure and risk factors among vegetable farmers in Benguet, Philippines?", "answer_source": "NOT_FOUND. The text does not provide information about the aim of the 2001 study.", "answer_summary": "The aim of the 2001 study was to investigate pesticide exposure and its risk factors among vegetable farmers in Benguet, Philippines.", "agree": false}]}
{"stringID": "pubmed_000016", "qa_pairs": [{"question": "1. Which specific region of the heart does the Isl1 positive population reside in during heart development?", "answer_source": "The Isl1 positive population resides in the secondary heart field (shf), contributing to the outflow tract, right ventricle, atria, and to a small extent, the left ventricle.", "answer_summary": "NOT_FOUND. The text does not specify which region of the heart the Isl1 positive population resides in during heart development.", "agree": false}, {"question": "2. Which cardiac pole(s) do Isl1-marked shf cells contribute to in the developing cardiac tube?", "answer_source": "Isl1-marked shf cells contribute to both the venous and arterial poles of the cardiac tube. However, other cells from the shf contribute only to the arterial pole.", "answer_summary": "NOT_FOUND. The text mentions that Isl1-marked shf cells are suggested to derive from the first and secondary heart fields, but it does not specify which cardiac pole they contribute to in the developing cardiac tube.", "agree": false}, {"question": "3. Can Isl1+/c-kit-/sca-1- progenitors be found in the postnatal heart?", "answer_source": "YES. According to the text, Isl1+/c-kit-/sca-1- progenitors were identified in the postnatal heart.", "answer_summary": "Yes, according to the text, Isl1+/c-kit-/sca-1- progenitors have been identified and isolated from both embryonic and adult hearts.", "agree": true}, {"question": "4. Do all c-kit+ cells express Isl1 in the heart?", "answer_source": "NOT_FOUND.  The text mentions that there are isl1+/c-kit- cells in the postnatal heart. Therefore, not all c-kit+ cells express Isl1.", "answer_summary": "NOT_FOUND.  The text mentions that there are two populations of cardiac progenitor or stem cells, one is Isl1+ and the other is c-kit+/sca-1+. It also states that new evidence suggests a connection between the two populations and that they may", "agree": false}, {"question": "5. Which genes, including Isl1, Nkx2.5, and Flk1, may be expressed by primordial cardiovascular precursors in the shf?", "answer_source": "NOT_FOUND. The text mentions Isl1 expression in the shf, but it does not explicitly state the expression of Nkx2.5 and Flk1 genes.", "answer_summary": "NOT_FOUND. The text mentions Isl1 and c-kit genes being expressed by cardiac progenitor cells, but it does not explicitly state that they are expressed by primordial cardiovascular precursors in the shf (sheltering homeobox domain).", "agree": false}, {"question": "6. How does the shf cooperate with the first heart field (fhf) and cardiac neural crest cells during heart development?", "answer_source": "NOT_FOUND. The text does not provide information on how the shf cooperates with the first heart field (fhf) and cardiac neural crest cells during heart development.", "answer_summary": "NOT_FOUND. The text mentions that cardiac progenitor cells may derive from the first and secondary heart fields and from the neural crest, but it does not provide specific information on how these populations cooperate during heart development.", "agree": false}, {"question": "7. Which cardiac structure does the fhf form the early cardiac tube and generate?", "answer_source": "The fhf (secondary heart field) forms the early cardiac tube and generates the outflow tract, right ventricle, atria, and to a small extent, the left ventricle.", "answer_summary": "NOT_FOUND. The text does not mention the formation of the early cardiac tube by any specific structure or cell type, including the cardiac progenitor cells.", "agree": false}, {"question": "8. Which cardiac structure does the fhf lineage form the early cardiac tube and generate?", "answer_source": "The fhf lineage forms the early cardiac tube and generates the outflow tract during tube looping.", "answer_summary": "NOT_FOUND. The text does not mention the Fhf lineage in relation to the cardiac tube or early cardiac development.", "agree": false}, {"question": "9. What additional cells and structures does the shf contribute to the maturing heart?", "answer_source": "The shf contributes to the outflow tract, right ventricle, atria, and to a small extent, the left ventricle. It provides myocardium to the outflow tract during tube looping. Isl1+/c - kit negative (c-kit-)/stem", "answer_summary": "NOT_FOUND.  The text mentions the first and secondary heart fields as potential sources of cardiac progenitor cells, but it does not provide information about the structures or cells contributed by the shielding plate (shf) to the maturing heart.", "agree": false}]}
{"stringID": "pubmed_000017", "qa_pairs": [{"question": "1. What is the typical survival time for primary diffuse leptomeningeal gliomatosis (PDLG) patients with astrocytic cells?", "answer_source": "The text describes a patient with PDLG and astrocytic cells who survived for twenty-two months after diagnosis, which is the longest survival time described thus far for this subtype. However, the text does not provide information on a typical survival time for PDLG patients with astrocytic", "answer_summary": "The text describes a case study of a patient with PDLG and astrocytic cells who survived for twenty-two months after diagnosis. Therefore, the longest survival time described for this specific subtype of PDLG is twenty-two months. However, the text also states that the survival time is typically", "agree": false}, {"question": "2. Which dermatome levels were affected by sensory deficits in the male patient with PDLG?", "answer_source": "T8-10.", "answer_summary": "T8-10.", "agree": true}, {"question": "3. What was the initial diagnosis based on the results of MRI and histopathology?", "answer_source": "Primary diffuse leptomeningeal gliomatosis with astrocytic cells (grade III)", "answer_summary": "Primary diffuse leptomeningeal gliomatosis with astrocytic cells (grade III)", "agree": true}, {"question": "4. How did the patient's condition progress after 13 months, as indicated by spinal MRI?", "answer_source": "Tumor progression.", "answer_summary": "Tumor progression.", "agree": true}, {"question": "5. What was the treatment regimen for the patient's second-line chemotherapy?", "answer_source": "Five cycles of irinotecan and bevacizumab.", "answer_summary": "Five cycles of irinotecan and bevacizumab.", "agree": true}, {"question": "6. What was the patient's clinical status following 22 months after diagnosis?", "answer_source": "The patient died following 22 months after diagnosis.", "answer_summary": "The patient died following 22 months after diagnosis.", "agree": true}, {"question": "7. Which symptoms did the patient experience five months after a generalized epileptic seizure?", "answer_source": "The patient experienced gait disturbance, paraparesis, and sensory deficits in the dermatomes T8-10 five months after a generalized epileptic seizure.", "answer_summary": "The patient experienced gait disturbance, paraparesis, and sensory deficits in the dermatomes T8-10 five months after a generalized epileptic seizure.", "agree": true}, {"question": "8. What were the findings in the CSF analysis?", "answer_source": "NOT_FOUND. The text does not provide information about the CSF analysis findings.", "answer_summary": "NOT_FOUND. The text does not mention any findings from a CSF analysis.", "agree": true}, {"question": "9. What did T1-weighted images reveal before radiochemotherapy regarding leptomeningeal gadolinium-enhancement and myelon spinal edema?", "answer_source": "The text does not provide information on the findings of T1-weighted images before radiochemotherapy regarding leptomeningeal gadolinium-enhancement and myelon spinal edema.  Question: 10. What was the survival time of the patient after diagnosis?", "answer_summary": "The text does not provide information on the findings of T1-weighted images before radiochemotherapy regarding leptomeningeal gadolinium-enhancement and myelon spinal edema.  Question: 10. What was the survival time of the patient after diagnosis?", "agree": true}, {"question": "10. How did the imaging results change following radiochemotherapy?", "answer_source": "NOT_FOUND. The text does not provide information on how the imaging results changed following radiochemotherapy.", "answer_summary": "Partial tumor regression was observed following radiochemotherapy.", "agree": false}]}
{"stringID": "pubmed_000018", "qa_pairs": [{"question": "1. What is the role of MAU as a predictor of cardiovascular disease (CVD) and death among subjects with type 2 diabetes (T2D)?", "answer_source": "MAU is a predictor of CVD and death among subjects with T2D. (reference: 13)  Question: 2. What is MAU one of the earliest clinical signs for?  Answer: MAU is one of the earliest clinical signs for diabetic neph", "answer_summary": "NOT_FOUND. The text does not provide information on the role of MAU as a predictor of CVD and death among subjects with T2D.", "agree": false}, {"question": "2. Which clinical sign is one of the earliest indicators for diabetic nephropathy in subjects with T2D?", "answer_source": "Microalbuminuria (MAU)", "answer_summary": "Microalbuminuria (MAU)", "agree": true}, {"question": "3. What is the risk of developing end-stage renal disease (ESRD) for hypertensive T2D individuals with MAU?", "answer_source": "The text states that hypertensive T2D individuals with MAU have an increased risk of developing ESRD. (4) Therefore, the answer is:  An increased risk.  However, the text does not provide specific numbers or percentages, so the exact risk cannot be determined from the given information", "answer_summary": "NOT_FOUND. The text does not provide information on the risk of developing end-stage renal disease (ESRD) for hypertensive T2D individuals with microalbuminuria (MAU).", "agree": false}, {"question": "4. How does high blood pressure (Htn) contribute to the risk of CVD and diabetic nephropathy?", "answer_source": "High blood pressure (Htn) is a risk factor for both cardiovascular disease (CVD) and diabetic nephropathy. (text: \"risk factors known to be associated with cvd and diabetic nephropathy are high blood pressure (bp) and elevated gly", "answer_summary": "NOT_FOUND. The text describes the relationship between Htn and the risk of microalbuminuria (MAU) among Cuban Americans with Type 2 Diabetes (T2D), but it does not explicitly state how Htn contributes to the risk of CVD and diabetic neph", "agree": false}, {"question": "5. What is the impact of elevated glycosylated hemoglobin on the risk of CVD and diabetic nephropathy?", "answer_source": "Elevated glycosylated hemoglobin (A1c) is a risk factor for cardiovascular disease (CVD) and diabetic nephropathy in individuals with type 2 diabetes (T2D). (Text: lines 5-6)", "answer_summary": "NOT_FOUND. The text only mentions the relationship between elevated glycosylated hemoglobin and microalbuminuria in Cuban Americans with Type 2 Diabetes. It does not provide information on the impact of elevated glycosylated hemoglobin", "agree": false}, {"question": "6. Compared to other Hispanic subgroups, what are the serum cholesterol and systolic blood pressure levels for Cuban Americans?", "answer_source": "The text states that Cuban Americans have higher serum cholesterol and systolic blood pressure than Puerto Ricans and Mexican Americans.", "answer_summary": "NOT_FOUND. The text does not provide information on serum cholesterol levels for Cuban Americans. The text mentions the measurement of blood pressure but not systolic blood pressure levels specifically for Cuban Americans.", "agree": false}, {"question": "7. Among Hispanics, which subgroup has the highest proportion of hypertension and mean serum creatinine levels?", "answer_source": "Cuban Americans.", "answer_summary": "NOT_FOUND. The text provided does not mention Hispanics in general or any specific subgroup in relation to hypertension or mean serum creatinine levels. The text only discusses Cuban Americans with Type 2 Diabetes and their likelihood of having microalbuminuria, and the", "agree": false}, {"question": "8. What percentage of diabetes-related deaths occur among Cuban Americans aged 35 and older?", "answer_source": "NOT_FOUND. The text does not provide information on the percentage of diabetes-related deaths among Cuban Americans aged 35 and older.", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of diabetes-related deaths among Cuban Americans aged 35 and older.", "agree": true}]}
{"stringID": "pubmed_000019", "qa_pairs": [{"question": "1. What is the leading cause of mortality and morbidity in both developed and developing countries, ranking second to which disease?", "answer_source": "The leading cause of mortality and morbidity in both developed and developing countries ranks second to cancer.", "answer_summary": "In India, breast cancer accounts for 19-34% of all cancer cases among women and is the leading cause of mortality and morbidity among women, ranking second to none specified in the text.", "agree": false}, {"question": "2. Which type of cancer is gradually becoming more common than cancer of the cervix?", "answer_source": "Breast cancer.", "answer_summary": "Breast cancer. According to the text, breast cancer accounts for 19-34% of all cancer cases among women in India.", "agree": false}, {"question": "3. How does early diagnosis of breast cancer impact treatment and survival rate?", "answer_source": "Early diagnosis of breast cancer influences early treatment, yielding a better survival rate.", "answer_summary": "Early diagnosis of breast cancer offers the greatest chance of long-term survival and treatment. (Text)", "agree": false}, {"question": "4. What was the breast self-examination (BSE) practice frequency of one specific participant in the study?", "answer_source": "The participant was practicing BSE occasionally.", "answer_summary": "NOT_FOUND. The text does not provide information about the BSE practice frequency of any specific participant in the study.", "agree": false}, {"question": "5. In what ways is BSE a beneficial method for screening for breast cancer?", "answer_source": "Early diagnosis through BSE has been reported to influence early treatment and yield a better survival rate.", "answer_summary": "NOT_FOUND. The text mentions that BSE is an important viable substitute for early detection of breast cancer, but it does not provide specific information on the benefits of BSE for screening.", "agree": false}, {"question": "6. What were the objectives of the study regarding assessing the level of knowledge and effectiveness of a teaching program on BSE among degree female students?", "answer_source": "The objectives of the study were to identify the level of knowledge and practice of BSE among degree female students and to reduce morbidity or mortality by teaching them BSE, which they can then pass on to their community.", "answer_summary": "The objectives of the study were: 1. To assess the level of knowledge of degree college female students on BSE. 2. To determine the effectiveness of a teaching program among degree college female students on BSE.", "agree": false}, {"question": "7. How can the incidence and prevalence of breast cancer be reduced?", "answer_source": "Encouraging the practice of breast self-examination among women can help in early detection and better survival rates. Incorporating breast self-examination in degree education curriculum can help spread awareness and reduce incidence and prevalence. (Text)  Therefore, the answer is: Incorporating", "answer_summary": "NOT_FOUND. The text does not provide information on how the incidence and prevalence of breast cancer can be reduced.", "agree": false}, {"question": "8. What were the study objectives for assessing the level of knowledge of degree college female students on BSE?", "answer_source": "The study aimed at identifying the level of knowledge and practice of BSE among degree female students, with the ultimate goal of reducing morbidity and mortality from breast cancer through early detection.", "answer_summary": "Objectives 1 and 3.", "agree": false}, {"question": "9. What was the intended teaching program for among degree college female students on BSE?", "answer_source": "The intended teaching program for degree college female students on BSE (Breast Self Examination) was to incorporate the concept into the curriculum.", "answer_summary": "NOT_FOUND. The text does not provide information on the intended teaching program for degree college female students on BSE.", "agree": false}, {"question": "10. At what significance level were the hypotheses tested in the study?", "answer_source": "NOT_FOUND. The text does not provide information about the significance level at which the hypotheses were tested in the study.", "answer_summary": "NOT_FOUND. The text does not provide information on the significance level at which the hypotheses were tested in the study.", "agree": true}, {"question": "11. What is the difference in knowledge of BSE between the pretest and post-test among degree college female students?", "answer_source": "NOT_FOUND. The text does not provide information on the difference in knowledge of BSE between the pretest and post-test among degree college female students.", "answer_summary": "NOT_FOUND. The text does not provide information on the difference in knowledge of BSE between the pretest and post-test among degree college female students.", "agree": true}]}
{"stringID": "pubmed_000020", "qa_pairs": [{"question": "1. How was Der p 1 isolated from house dust mite fecal pellets using which procedure?", "answer_source": "Der p 1 was isolated from house dust mite fecal pellets using a multistep procedure involving immunoaffinity chromatography on immobilized anti-Der p 1 mab (clone 4c1, Indoor Biotechnologies), removal of contaminating serine proteases", "answer_summary": "NOT_FOUND. The text does not provide information on how Der p 1 was isolated from house dust mite fecal pellets.", "agree": false}, {"question": "2. Which antibody (mAb) was used for immunoaffinity chromatography in the purification of Der p 1?", "answer_source": "The antibody (mAb) used for immunoaffinity chromatography in the purification of Der p 1 was anti-Der p 1 mab (clone 4c1) from Indoor Biotechnologies.", "answer_summary": "NOT_FOUND. The text does not mention which antibody was used for immunoaffinity chromatography in the purification of Der p 1.", "agree": true}, {"question": "3. Which protein inhibitor was employed to remove contaminating serine proteases during the purification of Der p 1?", "answer_source": "The protein inhibitor used to remove contaminating serine proteases during the purification of Der p 1 was immobilized soybean trypsin inhibitor (sigma chemical co.).", "answer_summary": "NOT_FOUND.  The text mentions the use of a cysteine protease inhibitor (e-64) during the immunization experiments, but it does not provide information about its use during the purification of Der p 1.", "agree": false}, {"question": "4. Which chromatography technique was used to remove low-molecular-mass contaminants from Der p 1?", "answer_source": "Fast protein liquid chromatography (fplc)", "answer_summary": "NOT_FOUND. The text does not mention which chromatography technique was used to remove low-molecular-mass contaminants from Der p 1.", "agree": false}, {"question": "5. How was the purity of Der p 1 confirmed using NH2-terminal sequencing, SDS-PAGE analysis, and enzymatic activity tests?", "answer_source": "The purity of Der p 1 was confirmed by NH2-terminal sequencing, SDS-PAGE analysis, and demonstration that its enzymatic activity was completely dependent on preactivation with cysteine and totally inhibited by e-64.", "answer_summary": "NOT_FOUND. The text does not provide information on how the purity of Der p 1 was confirmed using NH2-terminal sequencing, SDS-PAGE analysis, and enzymatic activity tests.", "agree": false}, {"question": "6. Which microtiter plate assay was used to determine the protein concentration of Der p 1, and what was its spectrophotometric confirmation?", "answer_source": "The protein concentration of Der p 1 was determined using a bicinchoninic acid (BCA) microtiter plate assay. Its spectrophotometric confirmation used the empirical absorption coefficient value for Der p 1 at 280 nm, which is 16.4", "answer_summary": "NOT_FOUND. The text does not provide information about the microtiter plate assay used to determine the protein concentration of Der p 1 or its spectrophotometric confirmation.", "agree": false}, {"question": "7. How was Der p 1 preactivated prior to its catalytic activity tests?", "answer_source": "Der p 1 was preactivated with 5 mm cysteine prior to its catalytic activity tests.", "answer_summary": "NOT_FOUND. The text does not provide information on how Der p 1 was preactivated prior to its catalytic activity tests.", "agree": true}, {"question": "8. Which fluorogenic peptide substrate was used to ascertain the catalytic activity of Der p 1, and which inhibitors were used to inhibit it?", "answer_source": "NOT_FOUND (The text mentions the use of e-64 as an inhibitor, but it does not specify a fluorogenic peptide substrate for the catalytic activity assay.)", "answer_summary": "The text does not provide information on the specific fluorogenic peptide substrate used to ascertain the catalytic activity of Der p 1. However, it mentions the use of the cysteine protease inhibitor E-64 to irreversibly block the proteolytic", "agree": false}]}
{"stringID": "pubmed_000021", "qa_pairs": [{"question": "[1. What specific symptoms did the patient experience in his lower extremities after the epidural steroid injection?", "answer_source": "The patient experienced paraplegia of the lower extremities, specifically conus medullaris syndrome, after the epidural steroid injection. This resulted in a loss of feeling in his legs.", "answer_summary": "The patient experienced paraplegia of the lower extremities after the epidural steroid injection.", "agree": true}, {"question": "2. What was the number of epidural steroid injections the patient had received prior to the development of paraplegia?", "answer_source": "NOT_FOUND.  The text does not mention the number of epidural steroid injections the patient had received prior to the development of paraplegia.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of epidural steroid injections the patient had received prior to the development of paraplegia.", "agree": true}, {"question": "3. What imaging technique was used to confirm the correct placement of the needle during the epidural steroid injection?", "answer_source": "NOT_FOUND. The text does not provide information on the imaging technique used to confirm the correct placement of the needle during the epidural steroid injection.", "answer_summary": "Epidurography.", "agree": false}, {"question": "4. How were the patient's lower extremities affected following the epidural steroid injection?", "answer_source": "Paraplegia of the lower extremities was noted in the patient.", "answer_summary": "The patient experienced paraplegia of the lower extremities after the epidural steroid injection.", "agree": true}, {"question": "5. What were the initial findings from the patient's magnetic resonance imaging study?", "answer_source": "UNREMARKABLE.", "answer_summary": "The initial magnetic resonance imaging study was unremarkable.", "agree": false}, {"question": "6. Where was the patient initially taken for emergency care following the onset of symptoms?", "answer_source": "The text does not provide information on where the patient was initially taken for emergency care following the onset of symptoms.  Answer: NOT_FOUND.", "answer_summary": "The text does not provide information on where the patient was initially taken for emergency care following the onset of symptoms.  Answer: NOT_FOUND.", "agree": true}, {"question": "7. What hospital did the patient eventually transfer to for further neurologic evaluation?", "answer_source": "NOT_FOUND.  The text does not mention the name of the hospital where the patient transferred for further neurologic evaluation.", "answer_summary": "NOT_FOUND. The text does not mention the name of the hospital where the patient transferred for further neurologic evaluation.", "agree": true}, {"question": "8. What neurological condition was diagnosed based on the patient's symptoms and imaging results?", "answer_source": "Conus medullaris syndrome.", "answer_summary": "Conus medullaris syndrome.", "agree": true}, {"question": "9. In what time period was the literature search conducted for articles related to complications, lumbar epidural steroid injections, and various neurological conditions?", "answer_source": "The literature search was conducted from 2002 to 2011.", "answer_summary": "The literature search was conducted from 2002 to 2011.", "agree": true}, {"question": "10. Which medical group administered the epidural steroid injection to the patient?]", "answer_source": "NOT_FOUND.  The text does not provide information about which medical group administered the epidural steroid injection to the patient.", "answer_summary": "NOT_FOUND.  The text does not provide information about which medical group administered the epidural steroid injection to the patient.", "agree": true}]}
{"stringID": "pubmed_000023", "qa_pairs": [{"question": "1. What specific neurodegenerative disorder is Alzheimer's disease (AD)?", "answer_source": "Alzheimer's disease (AD) is a neurodegenerative disorder.", "answer_summary": "Alzheimer's disease (AD) is a neurodegenerative disorder.", "agree": true}, {"question": "2. In what way is mental decline clinically characterized in Alzheimer's disease (AD)?", "answer_source": "Mental decline in Alzheimer's disease (AD) is clinically characterized by progressive mental decline.", "answer_summary": "NOT_FOUND.  The text does not provide information on how mental decline is clinically characterized in Alzheimer's disease.", "agree": false}, {"question": "3. How is increased production of amyloid-prone forms of APP related to the disease process of Alzheimer's disease (AD)?", "answer_source": "Increased production of amyloid-prone forms of APP is related to the disease process of Alzheimer's disease (AD) through the establishment and reinforcement of the Alzheimer amyloid cascade hypothesis. (Text)", "answer_summary": "The text states that the amyloid cascade hypothesis remains a robust model of AD neurodegeneration, meaning that increased production of amyloid-prone forms of APP is related to the disease process of Alzheimer's disease.", "agree": false}, {"question": "4. In what ways are APP processing and production of peptides involved in the disease process of Alzheimer's disease (AD)?", "answer_source": "The identification of mutations in the APP and PS genes that cause autosomal dominantly inherited AD and result in increased production of amyloid-prone forms of APP has established that APP processing and production of peptides are intimately involved in the disease process. This led to the", "answer_summary": "The text discusses the role of APOE, not APP, in Alzheimer's disease. Therefore, NOT_FOUND for the given question.", "agree": false}, {"question": "5. What are the potential intermediates in amyloid filament formation from small, soluble oligomers of the A peptide, also known as ADDLs, protofibrils, or A*56?", "answer_source": "The potential intermediates in amyloid filament formation from small, soluble oligomers of the A peptide are the ADDLs, protofibrils, or A*56.", "answer_summary": "NOT_FOUND. The text does not provide information on the potential intermediates in amyloid filament formation from small, soluble oligomers of the A peptide.", "agree": true}, {"question": "6. How do ADDLs affect long-term potentiation (LTP) in hippocampal slices?", "answer_source": "ADDLs inhibit long-term potentiation (LTP) in hippocampal slices.", "answer_summary": "NOT_FOUND. The text does not provide information about ADDLs (Amyloid-beta Derived Diffusible Laminae) and their effects on long-term potentiation in hippocampal slices.", "agree": false}, {"question": "7. According to the amyloid cascade hypothesis, what role do A oligomers play in neurodegeneration?", "answer_source": "A oligomers are neurotoxic and inhibit long-term potentiation (LTP), a cellular model of memory, in hippocampal. (Reference: 36)", "answer_summary": "A oligomers are a component of amyloid deposits in the context of the amyloid cascade hypothesis and are implicated in neurodegeneration.", "agree": false}, {"question": "8. What proteins are associated with amyloid formation in Alzheimer's disease (AD) and middle-aged Down Syndrome?", "answer_source": "The proteins associated with amyloid formation in Alzheimer's disease (AD) are the amyloid precursor protein (APP) and presenilin (PS). In middle-aged Down Syndrome, an extra copy of chromosome 21 leads to increased production of", "answer_summary": "Amyloid deposits contain proteins besides AÎ², such as ApoE.", "agree": false}]}
{"stringID": "pubmed_000024", "qa_pairs": [{"question": "1. What is the effect of aging on the bone fragility of musculoskeletal tissues?", "answer_source": "The text states that musculoskeletal tissues show increased bone fragility in the elderly.", "answer_summary": "The text mentions that musculoskeletal disorders, including fractures due to osteoporosis, are common problems affecting the elderly population. Therefore, the text implies that aging leads to decreased bone strength and increased fragility.  Answer:  Aging leads to decreased bone strength", "agree": false}, {"question": "2. How does cartilage resilience change in the elderly in relation to musculoskeletal tissues?", "answer_source": "The text states that the elderly experience a loss of cartilage resilience in their musculoskeletal tissues.", "answer_summary": "NOT_FOUND. The text mentions osteoarthritis as one of the musculoskeletal disorders of the elderly, but it does not provide information on how cartilage resilience specifically changes in relation to other musculoskeletal tissues in the elderly population.", "agree": false}, {"question": "3. In what way does muscular strength decline in the elderly population?", "answer_source": "Muscular strength decreases in the elderly population. (Text)", "answer_summary": "NOT_FOUND. The text mentions musculoskeletal disorders but does not provide information on muscular strength decline in the elderly population.", "agree": false}, {"question": "4. How does fat redistribution in the elderly impact the ability of tissues to perform normal functions?", "answer_source": "Fat redistribution decreases the ability of tissues to carry out their normal functions in the elderly.", "answer_summary": "NOT_FOUND. The text does not provide information on fat redistribution and its impact on the ability of tissues to perform normal functions in the elderly.", "agree": true}, {"question": "5. What are the physical, psychological, and mortality consequences of loss of mobility and physical independence due to arthropathies and fractures in the elderly?", "answer_source": "The loss of mobility and physical independence due to arthropathies and fractures in the elderly can have devastating consequences, both physically and psychologically, and can also lead to increased mortality rates. (Text)", "answer_summary": "NOT_FOUND. The text mentions the loss of mobility and physical independence due to musculoskeletal disorders, specifically arthropathies and fractures, but it does not provide information on the specific consequences, such as psychological or mortality effects.", "agree": false}, {"question": "6. What are the primary causes of fractures in the elderly population?", "answer_source": "The primary causes of fractures in the elderly population are falls and osteoporosis. (Text)", "answer_summary": "NOT_FOUND. The text mentions that fractures are a common musculoskeletal disorder among the elderly, but it does not provide information on their causes.", "agree": false}, {"question": "7. Which type of falls are most common among geriatric patients?", "answer_source": "Low-impact falls, even from standing height.", "answer_summary": "NOT_FOUND. The text mentions musculoskeletal disorders in general among the elderly, but it does not specify which types of falls are most common.", "agree": false}, {"question": "8. What are the intrinsic and extrinsic risk factors contributing to falling in the elderly?", "answer_source": "NOT_FOUND. The text mentions that falls are a major contributor to fractures in the elderly, but it does not provide information on the specific intrinsic and extrinsic risk factors for falling.", "answer_summary": "NOT_FOUND. The text does not provide information on the risk factors for falling in the elderly, only mentions that musculoskeletal disorders can lead to mobility loss and physical independence issues in this population.", "agree": false}, {"question": "9. How does osteoporosis impact bone fragility and the risk of fractures?", "answer_source": "Osteoporosis leads to increased bone fragility and an increased risk of fractures.", "answer_summary": "Osteoporosis leads to decreased bone density and strength, increasing the risk of fractures.", "agree": true}, {"question": "10. What diagnostic technique is most commonly used for diagnosing osteoporosis?", "answer_source": "NOT_FOUND. The text mentions the diagnosis of osteoporosis but does not specify the diagnostic technique used.", "answer_summary": "NOT_FOUND. The text does not provide information on the diagnostic technique most commonly used for diagnosing osteoporosis.", "agree": false}, {"question": "11. What is the prevalence of osteoporosis according to the biomedical article?", "answer_source": "NOT_FOUND. The text mentions that osteoporosis is a cause of increased bone fragility, but it does not provide any specific information about its prevalence.", "answer_summary": "NOT_FOUND. The text mentions that osteoporosis is one of the musculoskeletal disorders of the elderly, but it does not provide any specific information about its prevalence.", "agree": true}]}
{"stringID": "pubmed_000025", "qa_pairs": [{"question": "1. What is the level of disability associated with migraine?", "answer_source": "Migraine is associated with significant disability in the sufferer.  Question: 2. What is chronic migraine (CM) and how is it defined?  Answer: Chronic migraine (CM) is defined as at least 15 days of headache per month in which at", "answer_summary": "NOT_FOUND. The text does not provide information on the level of disability associated with migraine.", "agree": false}, {"question": "2. How many days per month do individuals with chronic migraine experience headaches, and how many of these days meet migraine criteria or require specific medications?", "answer_source": "Individuals with chronic migraine experience at least 15 days of headache per month, and eight of these days fulfill migraine criteria and/or require specific medications.", "answer_summary": "Chronic migraine is defined as headaches occurring 15 or more days per month. However, the text does not provide information on how many of these days meet migraine criteria or require specific medications.  Therefore, the answer is: NOT_FOUND.", "agree": false}, {"question": "3. At what age does chronic migraine typically begin in individuals with a history of episodic migraine?", "answer_source": "The text does not provide information on the typical age chronic migraine begins in individuals with a history of episodic migraine.  Question: 4. How many days of headache per month are required for a diagnosis of chronic migraine?  Answer:  At least 15 days of", "answer_summary": "NOT_FOUND. The text does not provide information on the age at which chronic migraine typically begins in individuals with a history of episodic migraine.", "agree": false}, {"question": "4. Which identified risk factors are associated with the development of chronic migraine or the progression of episodic migraine to chronic migraine?", "answer_source": "The identified risk factors associated with the development of chronic migraine or the progression of episodic migraine to chronic migraine are medication overuse, obesity, sleep problems, and psychiatric comorbidity. [712]", "answer_summary": "NOT_FOUND. The text does not provide information on risk factors associated with the development or progression of chronic migraine or the progression of episodic migraine to chronic migraine.", "agree": true}, {"question": "5. What psychiatric conditions have been demonstrated to be associated with migraine?", "answer_source": "According to the text, studies have demonstrated an association between migraine and several psychiatric conditions. However, the text does not specify which psychiatric conditions were identified in the studies. Therefore, the answer is:  [8, 9]  This is a reference to the studies mentioned in the text,", "answer_summary": "Psychiatric conditions have been demonstrated to be associated with migraine in 65.9% of individuals with chronic migraine from the community. The specific conditions are not mentioned in the text.", "agree": false}, {"question": "6. What are the potential limitations of population studies and clinic-based studies when it comes to assessing demographic data and psychiatric comorbidity in individuals with chronic migraine?", "answer_source": "NOT_FOUND. The text does mention the lack of comparison between the frequency of psychiatric disorders in community and tertiary settings, but it does not discuss potential limitations of population studies and clinic-based studies specifically when it comes to assessing demographic data and psychiatric comorbidity in individuals with", "answer_summary": "NOT_FOUND. The text mentions discrepancies between population-based and clinic-based studies, but it does not provide specific limitations for each type of study.", "agree": false}, {"question": "7. How do individuals with migraine and comorbid psychiatric disorders compare to those without psychiatric disorders in terms of healthcare usage?", "answer_source": "NOT_FOUND. The text does not provide information on healthcare usage comparison between individuals with migraine and comorbid psychiatric disorders and those without psychiatric disorders.", "answer_summary": "NOT_FOUND. The text does not provide information on healthcare usage for individuals with or without psychiatric disorders.", "agree": true}, {"question": "8. In which Brazilian city was the study on demographic data and psychiatric comorbidity in individuals with chronic migraine conducted?", "answer_source": "NOT_FOUND.  The text does not provide information about the location of the study.", "answer_summary": "NOT_FOUND.  The text does not provide information about the location of the study in Brazil.", "agree": true}, {"question": "9. How many inhabitants aged 10 years or older were included in the study, and what were the phases of the study?", "answer_source": "NOT_FOUND. The text does not provide information on the number of inhabitants included in the study or the phases of the study.", "answer_summary": "NOT_FOUND. The text does not provide information on the number of inhabitants aged 10 years or older included in the study or the phases of the study.", "agree": true}]}
{"stringID": "pubmed_000026", "qa_pairs": [{"question": "1. What is the sole metabolite of m1dg in rats?", "answer_source": "6-oxo-m1dg (3-(2-deoxy--d-erythro-pentofuranosyl)-pyrimido[1,2-]purine-6,10(3h,5h)-dione)", "answer_summary": "The sole metabolite of m1dg in rats that is mentioned in the text is 6-oxo-m1dg.", "agree": false}, {"question": "2. Which reagents were obtained from Thermo Fisher Scientific for the reaction?", "answer_source": "NOT_FOUND. The text does not mention which reagents were obtained from Thermo Fisher Scientific for the reaction.", "answer_summary": "NOT_FOUND. The text does not mention any reagents obtained from Thermo Fisher Scientific.", "agree": true}, {"question": "3. At what temperature and for how long was the reaction held?", "answer_source": "NOT_FOUND. The text does not provide information on the temperature or length of time for the reaction held.", "answer_summary": "NOT_FOUND. The text does not provide information on the temperature or length of time for the reaction.", "agree": true}]}
{"stringID": "pubmed_000027", "qa_pairs": [{"question": "* What is the maximum vas score in the scapular area?", "answer_source": "The maximum vas score in the scapular area was rated between 70 and 80 mm.", "answer_summary": "NOT_FOUND.  The text does not provide information about the maximum Vas score in the scapular area.", "agree": false}, {"question": "* What is the normal range for serum magnesium levels?", "answer_source": "NOT_FOUND.  The text does not provide information about normal serum magnesium levels.", "answer_summary": "NOT_FOUND.  Question: * What is the cause of postherpetic neuralgia?  Answer:  NOT_FOUND.  Question: * What is the name of the chronic pain syndrome discussed in the text?  Answer:  Postherpet", "agree": false}, {"question": "* At what serum magnesium level was the intravenous infusion of magnesium sulfate stopped?", "answer_source": "NOT_FOUND. The text does not mention the serum magnesium level or the infusion of magnesium sulfate.", "answer_summary": "NOT_FOUND. The text does not provide information on the serum magnesium level at which the intravenous infusion of magnesium sulfate was stopped.", "agree": true}, {"question": "* How was magnesium administered during the study?", "answer_source": "NOT_FOUND. The text does not mention the administration of magnesium.", "answer_summary": "Transforaminal epidural injection of magnesium sulphate.", "agree": false}, {"question": "* What was the volume and composition of the epidural injection containing magnesium?", "answer_source": "NOT_FOUND. The text does not mention the volume or composition of the epidural injection containing magnesium.", "answer_summary": "Magnesium sulphate was the substance injected epidurally in the given case. The volume was not specified in the text.", "agree": false}, {"question": "* How frequently were TFEMIs performed during the study?", "answer_source": "NOT_FOUND. The text does not mention the frequency of TFEMIs (Transcutaneous Electrical Nerve Stimulation or other types of interventions) during the study.", "answer_summary": "NOT_FOUND. The text does not provide information on the frequency of transforaminal epidural injections of magnesium sulphate performed during the study.", "agree": true}]}
{"stringID": "pubmed_000028", "qa_pairs": [{"question": "1. In what location does occlusion typically occur in CRVO, according to the article?", "answer_source": "The occlusion may occur at the level of or posterior to the lamina cribrosa.", "answer_summary": "Central retinal vein occlusion (CRVO) involves occlusion of the central retinal vein.", "agree": false}, {"question": "2. Which anatomical structure could occlusion occur at or posterior to in CRVO?", "answer_source": "The central retinal vein occlusion (CRVO) occlusion could occur at or posterior to the lamina cribrosa.", "answer_summary": "Central retinal vein occlusion (CRVO) can occur at or posterior to the retina.", "agree": true}, {"question": "3. What is the current understanding regarding the pathogenesis of CRVO?", "answer_source": "A combination of vascular, anatomic, and inflammatory factors may contribute to the pathogenesis of CRVO. (NOT_FOUND: exact cause or mechanism)", "answer_summary": "NOT_FOUND. The text does not provide information on the current understanding regarding the pathogenesis of CRVO.", "agree": false}, {"question": "4. Why is FA assessment important for evaluating disease severity and classifying CRVO?", "answer_source": "FA assessment is important for evaluating disease severity and classifying CRVO because it provides adequate information for distinguishing between the two types of CRVO, ischemic and nonischemic. This information is crucial for determining the prognosis of visual acuity and the risk of developing secondary neovascular glau", "answer_summary": "FA assessment is important for evaluating disease severity and classifying CRVO as it is used in conjunction with optical coherence tomography imaging in this study to quantify the areas of peripheral retinal nonperfusion.", "agree": false}, {"question": "5. What is the prognosis for visual acuity in patients with ischemic CRVO?", "answer_source": "The prognosis for visual acuity in patients with ischemic CRVO is poor.", "answer_summary": "NOT_FOUND.  Question: 6. How many intravitreal injections were given on average in each group?  Answer:  The text does not provide the average number of intravitreal injections for each group.", "agree": false}, {"question": "6. How is VEGF upregulation associated with ischemic CRVO?", "answer_source": "Ischemic CRVO is associated with a significant upregulation of VEGF.", "answer_summary": "NOT_FOUND. The text does not provide information on VEGF upregulation in relation to ischemic CRVO.", "agree": false}, {"question": "7. Which retinal circulation area does conventional FA imaging cover?", "answer_source": "The text does not provide information on which retinal circulation area conventional FA imaging covers.  Question: 8. What is the incidence of secondary neovascular glaucoma in ischemic CRVO?  Answer:  The incidence of secondary neovascular glaucoma", "answer_summary": "Ultrawide-field fluorescein angiography is mentioned in the text. Therefore, the conventional FA imaging covers an area larger than a standard FA. However, the text does not provide the exact size or measurement of the area covered by ultrawide-field FA imaging.", "agree": false}, {"question": "8. What are the names of the two commercially available ultrawide-field systems for FA and imaging peripheral retina?", "answer_source": "NOT_FOUND. The text mentions fluorescein angiographic (FA) assessment, but it does not specify the names of any particular ultrawide-field systems for FA and imaging peripheral retina.", "answer_summary": "NOT_FOUND. The text mentions the use of ultrawide-field fluorescein angiography but does not specify the brand or model of the systems used.", "agree": false}, {"question": "9. How is peripheral retinal ischemia linked to increased VEGF production?", "answer_source": "NOT_FOUND. The text mentions that ischemic CRVO is associated with a significant upregulation of VEGF, but it does not provide information on how peripheral retinal ischemia leads to increased VEGF production.", "answer_summary": "NOT_FOUND. The text does not provide information on the link between peripheral retinal ischemia and increased VEGF production.", "agree": true}, {"question": "10. In which time frame did the study evaluating the association between peripheral retinal nonperfusion and ranibizumab injections take place?", "answer_source": "NOT_FOUND. The text does not provide information about a study evaluating the association between peripheral retinal nonperfusion and ranibizumab injections.", "answer_summary": "NOT_FOUND. The text does not provide information on the time frame of the study.", "agree": false}, {"question": "11. Which patient groups were excluded from the study?", "answer_source": "NOT_FOUND. The text does not provide information on which patient groups were excluded from the study.", "answer_summary": "NOT_FOUND. The text does not provide information on which patient groups were excluded from the study.", "agree": true}]}
{"stringID": "pubmed_000029", "qa_pairs": [{"question": "1. What complication of gastric bypass surgery is the cause of small bowel obstructions (SBO)?", "answer_source": "Small bowel obstructions (SBO) can be complications after gastric bypass surgery. The causes of SBO after gastric bypass include adhesions and intestinal herniation (IH). IH can occur due to multiple defects in the mesentery of the bow", "answer_summary": "Small bowel obstructions after gastric bypass surgery can be caused by internal hernias (1.6%).", "agree": false}, {"question": "2. Can small bowel obstructions (SBO) resulting from gastric bypass be chronic or acute?", "answer_source": "Yes, small bowel obstructions (SBO) resulting from gastric bypass can be chronic or acute.", "answer_summary": "NOT_FOUND.  The text does not provide information on whether SBO after gastric bypass can be chronic or acute.", "agree": false}, {"question": "3. What is the severity range of small bowel obstructions (SBO) related to gastric bypass?", "answer_source": "SBO related to gastric bypass can range from a nuisance to a life-threatening emergency.", "answer_summary": "NOT_FOUND. The text does not provide information on the severity range of SBO related to gastric bypass.", "agree": false}, {"question": "4. Which type of gastric bypass procedure is most commonly associated with small bowel obstructions (SBO) due to adhesions?", "answer_source": "Laparoscopic roux-en-y gastric bypass (LGB)", "answer_summary": "NOT_FOUND.  The text does not provide information on which type of gastric bypass procedure is most commonly associated with small bowel obstructions due to adhesions. The text only mentions the incidence and characteristics of SBO after antecolic antegastric bypass with non", "agree": false}, {"question": "5. What anatomical defect can occur in the mesentery of the bowel after laparoscopic Roux-en-Y gastric bypass (LGB)?", "answer_source": "Multiple defects can occur in the mesentery of the bowel after laparoscopic Roux-en-Y gastric bypass.", "answer_summary": "The text mentions that mesenteric defects were not closed in the study. Therefore, the anatomical defect that can occur in the mesentery of the bowel after laparoscopic Roux-en-Y gastric bypass is an open or unclosed mesenteric defect.", "agree": false}, {"question": "6. How is the presence of a defect in the roux limb related to the occurrence of small bowel obstructions (SBO) in antecolic bypass?", "answer_source": "A defect in the roux limb is associated with the occurrence of small bowel obstructions (SBO) in antecolic bypass.", "answer_summary": "In this study, the presence of a defect in the roux limb (mesenteric defect of the jejunojejunal anastomosis) was not closed, and 15 out of 249 primary laparoscopic roux-en-y gastric bypass procedures", "agree": false}, {"question": "7. What is the reported range of incidence for small bowel obstructions (SBO) after laparoscopic Roux-en-Y gastric bypass (LGB)?", "answer_source": "The reported incidence of SBO after LGB varies widely.", "answer_summary": "NOT_FOUND (The text provides information on the incidence of SBO after a specific type of LGB with nonclosure of the mesenteric defect, but it does not mention a range of reported incidences for SBO after LGB in general.)", "agree": false}]}
{"stringID": "pubmed_000030", "qa_pairs": [{"question": "1. What size thoracic catheter is used in the treatment procedure for removing the original prosthesis and delivering antibiotic cement?", "answer_source": "A 36 fr - diameter straight thoracic catheter is used in the treatment procedure.", "answer_summary": "A straight thoracic tube is used in the treatment procedure. The size is not specified in the text.", "agree": true}, {"question": "2. What diameter and length is the steinmann pin used for in the procedure?", "answer_source": "The steinmann pin used in the procedure is 3.0 mm in diameter and 22 cm in length.", "answer_summary": "The text does not provide the specific diameter and length of the Steinmann pin used in the procedure.", "agree": false}, {"question": "3. Which company provides the gentamicin bone cement used in the procedure?", "answer_source": "Depuy, warsaw, in, usa", "answer_summary": "NOT_FOUND. The text does not mention which company provides the gentamicin bone cement used in the procedure.", "agree": false}, {"question": "4. How much vancomycin is added to the gentamicin bone cement?", "answer_source": "2 g", "answer_summary": "NOT_FOUND. The text does not mention the specific amount of vancomycin added to the gentamicin bone cement.", "agree": false}, {"question": "5. Through which method is the cement rod inserted into the bone?", "answer_source": "The cement rod is inserted into the bone through an entry hole created at the center of the distal femur and proximal tibia.", "answer_summary": "The cement rod is inserted into the bone using an intramedullary nail technique.", "agree": false}, {"question": "6. What is the diameter of the cement rod used in the procedure?", "answer_source": "The cement rod used in the procedure has a diameter of 9 mm.", "answer_summary": "NOT_FOUND. The text does not provide information on the diameter of the cement rod used in the procedure.", "agree": false}, {"question": "7. At which locations are entry holes created for the insertion of the cement rod?", "answer_source": "The entry holes are created at the center of the distal femur and proximal tibia.", "answer_summary": "NOT_FOUND. The text does not mention the locations of entry holes for the cement rod.", "agree": false}, {"question": "8. How much antibiotic-impregnated cement is used to fill the proximal medullary canal of the tibia?", "answer_source": "NOT_FOUND. The text describes the use of antibiotic-impregnated cement in the treatment procedure, but it does not specify the amount used to fill the proximal medullary canal of the tibia.", "answer_summary": "The text does not provide information on the amount of antibiotic-impregnated cement used to fill the proximal medullary canal of the tibia.  Question: 9. What is the advantage of using a straight thoracic tube and a steinmann pin in the", "agree": false}, {"question": "9. How much antibiotic-impregnated cement is used to fill the space between the cement of the distal femur and the proximal tibia?", "answer_source": "NOT_FOUND. The text describes the use of antibiotic-impregnated cement in the treatment procedure, but it does not specify the amount used to fill the space between the cement of the distal femur and the proximal tibia.", "answer_summary": "NOT_FOUND. The text does not provide information on the amount of antibiotic-impregnated cement used.", "agree": false}, {"question": "10. Which antibiotic-impregnated cement rod technique was used in the treatment of how many infected TKA patients (specify the organism)?", "answer_source": "NOT_FOUND (The text mentions the use of vancomycin and gentamicin in the cement, but it does not specify which antibiotic-impregnated cement rod technique was used or how many patients were treated.)", "answer_summary": "NOT_FOUND. The text mentions the use of an antibiotic-impregnated cement intramedullary nail, but it does not specify which organism was infected or how many patients underwent this treatment.", "agree": true}]}
{"stringID": "pubmed_000031", "qa_pairs": [{"question": "1. What was the number of stroke participants and healthy controls in the study?", "answer_source": "NOT_FOUND. The text does not provide information on the number of stroke participants or healthy controls in the study mentioned.", "answer_summary": "The study involved 24 stroke participants and 24 healthy controls.", "agree": false}, {"question": "2. How long had stroke subjects experienced mental fatigue following their stroke?", "answer_source": "It is not explicitly stated in the text how long stroke subjects have experienced mental fatigue following their stroke.  Question: 3. What percentage of stroke survivors complain of mental fatigue?  Answer:  About 30-70% of stroke survivors complain of mental fatigue.", "answer_summary": "The stroke subjects had experienced mental fatigue for one year or more after their stroke.", "agree": false}, {"question": "3. How were study participants recruited for the research?", "answer_source": "NOT_FOUND. The text does not provide information on how study participants were recruited for the research.", "answer_summary": "The study recruited 24 well-rehabilitated stroke subjects who had experienced mental fatigue for one year or more after their stroke, and 24 healthy controls. (NOTE: The text does not provide information on how the participants were specifically contacted or invited to take part in the study.)", "agree": false}, {"question": "4. Did any stroke subjects exhibit hypertonia?", "answer_source": "NOT_FOUND. The text does not mention anything about hypertonia in stroke subjects.", "answer_summary": "NOT_FOUND. The text does not mention hypertonia in relation to the stroke subjects.", "agree": true}, {"question": "5. What type of information was obtained to determine the type of stroke for each participant?", "answer_source": "NOT_FOUND.  The text does not provide information on how the type of stroke was determined for each participant.", "answer_summary": "NOT_FOUND. The text does not provide information on the type of stroke for each participant.", "agree": true}, {"question": "6. Were control participants employed and able to work regularly?", "answer_source": "NOT_FOUND. The text does not provide information about control participants and their employment status.", "answer_summary": "NOT_FOUND. The text does not provide information about the employment status or work regularity of the control participants.", "agree": true}, {"question": "7. Which cognitive functions were assessed during the cognitive tests?", "answer_source": "NOT_FOUND. The text does not provide information on which cognitive functions were assessed during the cognitive tests mentioned in the text.", "answer_summary": "Processing speed and attention and speed were assessed during the cognitive tests.", "agree": false}]}
{"stringID": "pubmed_000032", "qa_pairs": [{"question": "1. Which inflammation-related diseases are known to be associated with CS?", "answer_source": "Chronic obstructive pulmonary disease and vascular diseases, including atherosclerosis and stroke.", "answer_summary": "Vascular diseases.", "agree": false}, {"question": "2. How does CS accelerate the development of atherosclerotic plaques?", "answer_source": "CS accelerates the development of atherosclerotic plaques through direct endothelial damage, increased smooth muscle proliferation, and decreased vasodilation. (Reference: [57])", "answer_summary": "CS contains toxic compounds like acrolein and other unsaturated aldehydes, which induce inflammatory mediator expression and vascular dysfunction, contributing to the development of atherosclerotic plaques. (Reference text)", "agree": false}, {"question": "3. What is the initial cause of vascular diseases according to the article?", "answer_source": "Endothelial damage, possibly caused by reactive oxygen species (ROS) and oxidative stress, is suggested as the initial cause of vascular diseases according to the article.", "answer_summary": "The initial cause of vascular diseases according to the article is cigarette smoke and its toxic compounds, specifically acrolein and other unsaturated aldehydes.", "agree": false}, {"question": "4. How does inhibition of oxidative stress protect human endothelial cells?", "answer_source": "The text states that inhibition of oxidative stress exerts protection in human endothelial cells. However, it does not provide specific information on how this inhibition occurs or what the protective effects are. Therefore, the answer is NOT_FOUND for this question.", "answer_summary": "NOT_FOUND. The text focuses on the effect of Korean red ginseng (KRG) on acrolein-induced COX-2 expression and apoptosis in human umbilical vein endothelial cells (HUVECs), but it does not explicitly mention ox", "agree": false}, {"question": "5. Which reactive oxygen species may play a role in mediating endothelial cell death?", "answer_source": "Reactive oxygen species (ROS) may play a role in mediating endothelial cell death. (Text)  Therefore, the answer is: ROS.", "answer_summary": "NOT_FOUND. The text mentions acrolein, an toxic compound in cigarette smoke, and its role in inducing apoptosis in human umbilical vein endothelial cells (huvecs), but it does not explicitly state which reactive oxygen species may be involved.", "agree": false}, {"question": "6. In which vascular diseases is oxidative stress a major factor?", "answer_source": "Oxidative stress is a major factor in vascular diseases such as hypertension, stroke, and atherosclerosis. (text)  Therefore, the answer is: hypertension, stroke, and atherosclerosis.", "answer_summary": "NOT_FOUND (The text mentions that cigarette smoke is a major risk factor for vascular diseases, but it does not specifically state which vascular diseases are associated with oxidative stress.)", "agree": false}, {"question": "7. Which traditional herbal medicine is used to treat vascular diseases and has antihypertensive effects?", "answer_source": "Korean red ginseng is NOT_FOUND to be explicitly mentioned in the text as a treatment for vascular diseases or having antihypertensive effects. The text only mentions it in passing without any context related to its medicinal properties.", "answer_summary": "Korean red ginseng (KRG)  Question: 8. What is the role of acrolein in vascular diseases?  Answer:  Acrolein is a toxic compound in cigarette smoke that induces inflammatory mediator expression and is related to vascular diseases.", "agree": false}, {"question": "8. How does KRG promote angiogenesis through the activation of which signaling pathway?", "answer_source": "NOT_FOUND. The text does not provide information on how Korean Red Ginge (KRG) promotes angiogenesis through the activation of a specific signaling pathway.", "answer_summary": "NOT_FOUND. The text does not provide information on how KRG promotes angiogenesis or which signaling pathway it activates. The text only mentions that KRG suppresses acrolein-induced COX-2 expression via inhibition of the p38 MAPK sign", "agree": false}, {"question": "9. In what ways can KRG be implicated in angiogenic therapies?", "answer_source": "NOT_FOUND. The text does not provide information about Korean red ginseng (KRG) and its role in angiogenic therapies.", "answer_summary": "KRG inhibits acrolein-induced COX-2 expression and apoptosis in human umbilical vein endothelial cells (huvecs) through the suppression of the p38 mitogen-activated protein kinase signaling pathway. (NOTE: Ang", "agree": false}, {"question": "10. What is the therapeutic mechanism of KRG's cytoprotective effect in cardiovascular diseases?", "answer_source": "NOT_FOUND. The text does not provide information on the therapeutic mechanism of Korean Red Ginseng (KRG) in cardiovascular diseases.", "answer_summary": "KRG suppresses acrolein-induced COX-2 expression via inhibition of the p38 MAPK signaling pathway. It also exhibits an inhibitory effect on acrolein-induced apoptosis.", "agree": false}, {"question": "11. Which human diseases are known to be contributed to by chronic inflammation?", "answer_source": "Chronic obstructive pulmonary disease and vascular diseases, including atherosclerosis and stroke.", "answer_summary": "Vascular diseases.", "agree": false}, {"question": "12. In what way is KRG involved in the regulation of inflammatory responses?", "answer_source": "NOT_FOUND. The text does not mention Korean red ginseng and its involvement in the regulation of inflammatory responses.", "answer_summary": "KRG suppresses acrolein-induced COX-2 expression via inhibition of the p38 MAPK signaling pathway.", "agree": false}]}
{"stringID": "pubmed_000033", "qa_pairs": [{"question": "1. Which year did Jinek et al. report on the use of Crispr/Cas9 technology for genome editing?", "answer_source": "2012  Question: 2. What method of gene editing has been displaced by Crispr/Cas9 in agriculture?  Answer:  antisense or RNA interference (RNAi)  Question: 3. What is the name of the protein associated", "answer_summary": "NOT_FOUND. The text does not provide the year when Jinek et al. reported on the use of Crispr/Cas9 technology for genome editing.", "agree": false}, {"question": "2. According to Carroll (2014), which genome editing methods were displaced by Crispr/Cas9?", "answer_source": "Zinc finger and transcription activator-like effector nucleases.", "answer_summary": "NOT_FOUND. The text mentions that Crispr/Cas9 offers a less equivocal means than previous approaches, but it does not specify which genome editing methods were displaced.", "agree": false}, {"question": "3. In what area of applications has Crispr/Cas9 been described as a game changer?", "answer_source": "Agriculture.", "answer_summary": "genome editing", "agree": false}, {"question": "4. What types of mutations have been reported with the use of Crispr/Cas9?", "answer_source": "Single nucleotide polymorphisms (SNPs) have been mentioned in the context of Crispr/Cas9 technology.", "answer_summary": "Biallelic mutations have been reported in Populus using Crispr/Cas9 technology.", "agree": true}, {"question": "5. In which hybrid Populus clone was the most efficient and consistent Crispr/Cas9 editing reported?", "answer_source": "NOT_FOUND. The text does not provide information on which specific Populus clone had the most efficient and consistent Crispr/Cas9 editing reported.", "answer_summary": "NOT_FOUND. The text does not provide information on the most efficient and consistent Crispr/Cas9 editing in a specific hybrid Populus clone.", "agree": true}, {"question": "6. Which gene family was the first to be targeted for genome editing in Populus using Crispr/Cas9?", "answer_source": "NOT_FOUND. The text does not mention which specific gene family was the first to be targeted for genome editing in Populus using Crispr/Cas9.", "answer_summary": "NOT_FOUND. The text mentions the first application of Crispr/Cas9 for biallelic mutations in Populus, but it does not specify which gene family was targeted.", "agree": false}]}
{"stringID": "pubmed_000034", "qa_pairs": [{"question": "* What is the optimal FePt alloy composition for synthesis?", "answer_source": "NOT_FOUND.  The text mentions the importance of determining the core composition for achieving the desired 50:50 FePt alloy composition, but it does not provide the optimal composition.", "answer_summary": "NOT_FOUND.  The text describes the analysis of the chemical composition of nanoparticle clusters using PCA and ICA on an EDX spectrum image, but it does not provide any information about the optimal FePt alloy composition for synthesis.", "agree": false}, {"question": "* In what form were EDX data collected from the sample?", "answer_source": "EDX data were acquired using an FEI Osiris TEM equipped with a high brightness Schottky X-FEG gun and a super-X EDX system.", "answer_summary": "The EDX data were collected in the form of a spectrum image (SI) in a scanning transmission electron microscope (STEM).", "agree": false}, {"question": "* What is the dimensionality of the resulting EDX spectrum image data set?", "answer_source": "NOT_FOUND. The text does not provide information on the dimensionality of the EDX spectrum image data set.", "answer_summary": "NOT_FOUND. The text does not provide information on the dimensionality of the EDX spectrum image data set.", "agree": true}, {"question": "* At what probe current were EDX spectrum images acquired?", "answer_source": "NOT_FOUND. The text does not provide information on the probe current used for EDX spectrum acquisitions.", "answer_summary": "NOT_FOUND. The text does not provide information about the probe current used to acquire the EDX spectrum images.", "agree": true}]}
{"stringID": "pubmed_000035", "qa_pairs": [{"question": "1. Which cellular signaling processes are controlled by ionic calcium (Ca) in eukaryotic cells?", "answer_source": "Ionic calcium (Ca) controls multiple cellular signaling processes in eukaryotic cells, including proliferation, gene expression, and neurotransmitter release.", "answer_summary": "Ionic calcium (Ca) in eukaryotic cells plays a role in the regulation of insulin secretion and neurotransmitter release through the Ca2+/calmodulin-dependent protein kinase II (CAMKII).  Question: 2. What is the name of the", "agree": false}, {"question": "2. What role do Ca-binding proteins such as calmodulin play in Ca signal transmission and amplification?", "answer_source": "Ca-binding proteins such as calmodulin play a pivotal role in Ca signal transmission and amplification by binding to Ca ions and activating specific protein targets, including Ca/calmodulin-dependent protein kinase II (CamKII). This binding allows for the phosphorylation of adjacent", "answer_summary": "Ca-binding proteins such as calmodulin play a role in Ca signal transmission and amplification by regulating the activity of Ca2+/calmodulin-dependent protein kinase II (CAMKII), which functions in insulin secretion and neurotransmitter release through common downstream mediators.", "agree": false}, {"question": "3. Which specific protein targets are activated when there are increases in the concentration of intracellular Ca?", "answer_source": "The specific protein target that is activated when there are increases in the concentration of intracellular Ca is the calcium/calmodulin-dependent protein kinase II (CAMKII).", "answer_summary": "The text mentions that there are common downstream mediators for CaMKII in insulin secretion and neurotransmitter release. It also states that metabolic memory, which is dependent on CaMKII, is reflected on the protein level by increased expression of proteins involved in glucose", "agree": false}, {"question": "4. How is the ca/calmodulin-dependent protein kinase II (CamKII) activated by Ca-calmodulin binding?", "answer_source": "The Ca-calmodulin binding to one of the CamKII subunits allows for the phosphorylation of an adjacent subunit at Thr, resulting in the activation of CamKII.", "answer_summary": "CamKII is activated by Ca-calmodulin binding. (The text states that CamKII functions through Ca-calmodulin binding, but it does not explicitly describe the activation process.)", "agree": false}, {"question": "5. What effect does calmodulin trapping have on the ca-calmodulin-dependent kinase activity of the complex?", "answer_source": "Calmodulin trapping confers ca-calmodulin-independent kinase activity to the complex and thus prolongs the ca signal.", "answer_summary": "NOT_FOUND. The text does not mention the effect of calmodulin trapping on the ca-calmodulin-dependent kinase activity of the complex.", "agree": true}, {"question": "6. How long does CamKII remain activated after the initial Ca signal has dissipated?", "answer_source": "The text mentions that calmodulin trapping confers Ca-calmodulin-independent kinase activity to the CamKII complex, which prolongs the Ca signal. Therefore, the length of CamKII activation after the initial Ca signal has dissipated is not explicitly stated in the text, but", "answer_summary": "NOT_FOUND. The text does not provide information on how long CamKII remains activated after the initial Ca signal has dissipated.", "agree": false}, {"question": "7. In what ways does CA signaling perpetuate effects and modulate gene expression and epigenetic profile of postsynaptic neurons through CamKII?", "answer_source": "CA signaling perpetuates effects and modulates gene expression and epigenetic profile of postsynaptic neurons through CamKII by activating CamKII in response to an increase in intracellular CA concentration. The CA-calmodulin complex binds to CamKII, allowing for the", "answer_summary": "NOT_FOUND. The text discusses how CA signaling and CamKII contribute to metabolic memory in pancreatic cells, leading to increased insulin secretion and altered protein expression. It does not provide information on how CA signaling specifically perpetuates effects and modulates gene expression and ep", "agree": false}, {"question": "8. How does CamKII participate in glucose-stimulated insulin secretion (GSIS)?", "answer_source": "NOT_FOUND. The text does not mention CamKII's role in glucose-stimulated insulin secretion.", "answer_summary": "CamKII participates in GSIS by facilitating metabolic memory in pancreatic cells, leading to increased insulin secretion. This is reflected on the protein level by increased expression of proteins involved in glucose sensing and Ca2+ -dependent vesicle secretion, as", "agree": false}, {"question": "9. Do pancreatic cells retain memory of prior activation?", "answer_source": "NOT_FOUND.  The text does not mention anything about pancreatic cells and their ability to retain memory.", "answer_summary": "Yes, pancreatic cells exhibit metabolic memory, which is dependent on CA2+/calmodulin-dependent protein kinase II (CAMKII).", "agree": false}]}
{"stringID": "pubmed_000036", "qa_pairs": [{"question": "1. How does functional status information contribute to an individual's or population's overall health assessment beyond the absence of disease?", "answer_source": "Functional status information provides a more comprehensive understanding of an individual's or population's health by assessing their capacity to carry out tasks and activities required for full engagement in all areas of life, as well as changes in body functions and structures arising from health conditions. It also considers the value people place on functioning", "answer_summary": "Functional status information, as described in the text, allows for evaluating interventions targeted at an individual's body, the individual as a whole, or the environment. This assessment goes beyond the absence of disease and permits the evaluation of effectiveness and cost-effectiveness of different interventions, contributing to comprehensive health", "agree": false}, {"question": "2. In what ways is functional status information important for understanding an individual's health capacity to carry out daily tasks and activities?", "answer_source": "Functional status information is important for understanding an individual's health capacity to carry out daily tasks and activities by providing insights into their ability to perform a set of tasks or actions in their real-life environment. It also takes into account the value people place on functioning in given domains in association with a health condition.", "answer_summary": "Functional status information is important for making FSI comparable and valuable by providing a common language and framework (ICF) that goes beyond disease and conceptualizes functioning from the individual's body, person, and lived experience, allowing for targeted interventions and evaluation of effectiveness and cost-effectiveness.", "agree": false}, {"question": "3. How does the health state impact an individual's ability to perform tasks and actions, and how can this be measured?", "answer_source": "The health state impacts an individual's ability to perform tasks and actions by influencing their capacity to carry out these activities. This can be measured by assessing their performance of tasks and actions in their real-life environment.", "answer_summary": "According to the text, the World Health Organization's International Classification of Functioning, Disability and Health (ICF) provides a common framework for describing functional status information, allowing for planning interventions targeted at an individual's body, the individual as a whole, or the environment. This framework permits the", "agree": false}, {"question": "4. What role does functional status information play in the development and monitoring of rehabilitative interventions?", "answer_source": "Functional status information is essential in the development and monitoring of rehabilitative interventions as it describes an individual's capacity to carry out tasks or actions and measures their performance in real-life environments. This information helps healthcare professionals assess the impact of health conditions on a person's life and tailor interventions to", "answer_summary": "Functional status information plays a role in making FSI comparable and valuable for planning interventions targeted at the individual's body, the individual as a whole, or the environment. It permits the evaluation of the effectiveness and cost effectiveness of different interventions for devising programs at the personal or societal level. (", "agree": false}, {"question": "5. Why is it essential for healthcare providers to collect and utilize functional status information in clinical practice?", "answer_source": "Functional status information is essential for healthcare providers to appreciate the full picture of an individual's health and understand the impact of their health state on their ability to carry out activities and tasks in real life. This information is integral to health and its achievement. (Reference text)  Therefore, the answer is:", "answer_summary": "It is essential for healthcare providers to collect and utilize functional status information in clinical practice to make it comparable and of value, using the World Health Organization's International Classification of Functioning, Disability and Health (ICF) as a common language and framework. This framework, based on the biopsychosocial", "agree": false}, {"question": "6. How does the lack of functional status information in health administrative records impact the ability to link diagnosis, treatment, and meaningful health outcomes for patients?", "answer_source": "NOT_FOUND. The text discusses the importance of functional status information in understanding and appreciating an individual's health, but it does not directly address the impact of the lack of such information in health administrative records on linking diagnosis, treatment, and health outcomes.", "answer_summary": "NOT_FOUND. The text discusses the importance of a common framework for functional status information (FSI) in health records and how the World Health Organization's International Classification of Functioning, Disability and Health (ICF) provides this framework. However, it does not directly address the impact of the", "agree": false}, {"question": "7. In which healthcare settings is functional status information typically collected and utilized, and why is it missing in others?", "answer_source": "NOT_FOUND. The text discusses the importance of functional status information in understanding an individual's or population's health, but it does not specify which healthcare settings typically collect and utilize this information or why it may be missing in others.", "answer_summary": "The text does not provide information on specific healthcare settings where functional status information is typically collected and utilized, or why it may be missing in others.  Question: 8. What is the name of the common language and framework for describing functional status information provided by the World Health Organization?  Answer:", "agree": false}]}
{"stringID": "pubmed_000037", "qa_pairs": [{"question": "1. What is the current recommendation for HIV screening during prenatal care, according to both the CDC and USPSTF?", "answer_source": "Universal HIV screening for all pregnant women entering prenatal care.", "answer_summary": "The text does not provide information on the current recommendation for HIV screening during prenatal care according to the CDC and USPSTF.  Question: 2. How many patients tested negative for HIV in the study?  Answer:  47,391  Question:", "agree": false}, {"question": "2. How do HIV-infected pregnant women and their infants benefit from early HIV screening and intervention?", "answer_source": "HIV-infected pregnant women and their infants benefit from early HIV screening and intervention by enabling the use of appropriate and timely interventions such as antiretroviral medications, reducing the chance of delivering an HIV-infected infant from approximately 25% without intervention to less than 2%.", "answer_summary": "NOT_FOUND. The text does not provide information on the benefits of early HIV screening and intervention for HIV-infected pregnant women and their infants.", "agree": false}, {"question": "3. What is the approximate risk of delivering an HIV-infected infant without intervention in the US?", "answer_source": "The approximate risk of delivering an HIV-infected infant without intervention in the US is approximately 25%.", "answer_summary": "NOT_FOUND. The text does not provide information on the approximate risk of delivering an HIV-infected infant without intervention in the US.", "agree": true}, {"question": "4. When was the first HIV test introduced, and what type of test was it?", "answer_source": "The first HIV test was introduced in 1985, and it was an enzyme immunoassay (EIA) test.", "answer_summary": "NOT_FOUND. The text does not provide information on when the first HIV test was introduced or what type of test it was.", "agree": false}, {"question": "5. Which assays are used for confirmatory HIV testing after a positive EIA result?", "answer_source": "Western blot or immunofluorescence assay.", "answer_summary": "Immunofluorescent testing is used for confirmatory HIV testing after a positive EIA result.", "agree": false}, {"question": "6. What is the positive predictive value of CPD's EIA for HIV detection in populations with varying HIV prevalence?", "answer_source": "The positive predictive value of CDC's EIA for HIV detection depends on the prevalence of HIV in the population tested.", "answer_summary": "NOT_FOUND. The text only provides the positive predictive value of EIA for HIV detection in this specific population, which is 54.3%.", "agree": false}, {"question": "7. Which factors may contribute to increased false positive rates in HIV EIA tests?", "answer_source": "In a low-prevalence population.", "answer_summary": "The text states that false positive HIV EIA tests at delivery are associated with young maternal age and nulliparity. Therefore, these factors may contribute to increased false positive rates in HIV EIA tests.", "agree": false}, {"question": "8. In which hospital and time frame was a study conducted to analyze HIV test results in pregnant women?", "answer_source": "NOT_FOUND. The text does not provide information about a specific study or hospital related to HIV testing in pregnant women.", "answer_summary": "The study was conducted at Parkland Hospital between the years 2005 and 2008.", "agree": false}, {"question": "9. Which HIV test was used for serum testing in the study?", "answer_source": "The text mentions the use of the enzyme immunoassay (EIA) for HIV testing in the past. Therefore, the answer is:  Answer: EIA", "answer_summary": "The HIV test used for serum testing in the study was the enzyme immunoassay (EIA) test.", "agree": false}, {"question": "10. How were HIV test results analyzed in the study?", "answer_source": "In a low-prevalence population, confirmatory testing using a western blot or immunofluorescence assay was implemented to account for false positive results using the enzyme immunoassay (EIA) HIV test. The false positive rate using the EIA is increased in a low", "answer_summary": "Statistical analyses included Pearson's chi-square and Student's t-test.", "agree": false}]}
{"stringID": "pubmed_000038", "qa_pairs": [{"question": "1. What percentage of adiposity variance can be attributed to genetic factors?", "answer_source": "40-70%  Question: 2. In which year was growth arrest-specific 6 (Gas6) cloned?  Answer:  1988  Question: 3. What is the role of Gas6 in cellular stresses such as", "answer_summary": "NOT_FOUND. The text does not provide information on the percentage of adiposity variance that can be attributed to genetic factors.", "agree": false}, {"question": "2. In what capacity is Growth arrest-specific 6 (Gas6) present in the human circulatory system?", "answer_source": "Gas6 is present in the human circulatory system as a secreted protein.", "answer_summary": "Gas6 is present in the human circulatory system in the form of its polymorphisms, specifically rs8191973 and rs8191974, which are associated with adiposity, systemic inflammation, and insulin resistance.", "agree": false}, {"question": "3. When was Gas6 first cloned and characterized?", "answer_source": "The text states that Gas6 was cloned in 1988 and characterized in 1993. Therefore, the answer is:  Answer: 1988 (cloned) and 1993 (characterized)", "answer_summary": "NOT_FOUND. The text does not provide information on when Gas6 was first cloned and characterized.", "agree": false}, {"question": "4. Under what conditions is Gas6 upregulated in fibroblasts?", "answer_source": "Gas6 is upregulated in growth-arrested fibroblasts.", "answer_summary": "NOT_FOUND. The text does not provide information on the conditions that upregulate Gas6 in fibroblasts.", "agree": false}, {"question": "5. Which tyrosine kinase receptor does Gas6 act as a ligand for?", "answer_source": "The tam (tyro-3/axl / mer) family tyrosine kinase receptor.", "answer_summary": "AXL", "agree": false}, {"question": "6. How does the Gas6/TAM pathway mediate its effects?", "answer_source": "The Gas6/TAM pathway mediates its effects through the interaction between Gas6, a secreted protein, and the TAM (tyro-3/axl/mer) family tyrosine kinase receptor.", "answer_summary": "NOT_FOUND. The text does not provide information on how the Gas6/TAM pathway mediates its effects.", "agree": false}, {"question": "7. In the context of obesity and insulin resistance, how is the relationship between the axl receptor, inflammatory cytokines, and Gas6/Axl signaling described in the article?", "answer_source": "NOT_FOUND. The text mentions that Gas6 is a ligand for the tam (tyro-3/axl/mer) family tyrosine kinase receptor, but it does not specifically discuss the relationship between the axl receptor, inflammatory cytokines, and", "answer_summary": "The article describes that boys with the gg genotype of axl rs2304232 exhibit higher il-6 and insulin levels, as well as increased insulin resistance (HOMA-IR), compared to a allele carriers. Additionally, there is a significant difference in hscrp", "agree": false}, {"question": "8. In which type of human adipose tissue are higher levels of Axl mRNA typically found in obese individuals compared to lean controls?", "answer_source": "NOT_FOUND.  The text mentions that gas6 is present in adipocytes, but it does not provide information about differences in Axl mRNA levels between obese and lean individuals.", "answer_summary": "NOT_FOUND. The text does not provide information on Axl mRNA levels in adipose tissue of obese individuals compared to lean controls.", "agree": false}, {"question": "9. What role does Gas6/Axl signaling play in recruiting macrophages and other immune cells into adipose tissue?", "answer_source": "NOT_FOUND.  The text mentions that Gas6 is expressed in adipocytes and is a ligand for the tam family tyrosine kinase receptor, but it does not provide information about the role of Gas6/Axl signaling in recruiting macrophages or other immune", "answer_summary": "NOT_FOUND. The text does not provide information on the role of Gas6/Axl signaling in recruiting macrophages and other immune cells into adipose tissue.", "agree": true}, {"question": "10. How is systemic inflammation linked to obesity, insulin resistance, and type 2 diabetes according to the article?", "answer_source": "NOT_FOUND. The text mentions the increasing occurrence of disorders such as type 2 diabetes during childhood as a consequence of childhood obesity, but it does not directly link systemic inflammation to obesity, insulin resistance, and type 2 diabetes in the context of the article.", "answer_summary": "The article finds that boys with certain genotypes of gas6 and axl polymorphisms have higher levels of systemic inflammation (hscrp), insulin resistance (HOMA-IR), and insulin levels compared to other genotypes. These findings suggest a link between systemic inflamm", "agree": false}]}
{"stringID": "pubmed_000039", "qa_pairs": [{"question": "1. What emotional issues have been reported in infertile women besides infertility itself?", "answer_source": "Anxiety and depression have been reported in infertile women besides infertility itself.", "answer_summary": "The text mentions that infertile women who undergo assisted reproductive treatment due to male factor infertility have reported less stress and depression than other women before the process, but that cultural and social factors, as well as the etiology of the process, could affect their mental health. Therefore, the", "agree": false}, {"question": "2. What is the range of anxiety prevalence in infertile couples?", "answer_source": "The frequency of anxiety in infertile couples has been reported in a wide range from 48% to 96%.", "answer_summary": "NOT_FOUND. The text does not provide information on the range of anxiety prevalence in infertile couples.", "agree": false}, {"question": "3. How can assisted reproductive techniques affect the mental health of fertile women due to male infertility?", "answer_source": "NOT_FOUND.  The text mentions that studies have shown that assisted reproductive techniques are accompanied by stress, anxiety, and depression, but it does not specifically discuss how these mental health issues may affect fertile women due to male infertility.", "answer_summary": "The text suggests that while fertile women undergoing assisted reproductive treatment for male infertility may experience less stress and depression than other women before the process, cultural and social factors, as well as the etiology of the process itself, could negatively impact their mental health. However, the study was", "agree": false}, {"question": "4. What is the difference in anxiety and depression levels between women with infertility and women with male factor infertility?", "answer_source": "Women with infertility have higher levels of anxiety and depression than women with male factor infertility.", "answer_summary": "NOT_FOUND. The text does not provide information on the anxiety and depression levels of women with infertility in comparison to those with male factor infertility.", "agree": false}, {"question": "5. In which societies is the woman considered the main source of fertility?", "answer_source": "NOT_FOUND.  The text does not provide any information about societies where women are considered the main source of fertility.", "answer_summary": "NOT_FOUND.  Question: 6. How many women were included in the study?  Answer:  70 women.  Question: 7. What was the exclusion criterion for the study?  Answer:  Stopping super ovulation induction", "agree": false}, {"question": "6. Which procedures are required daily for assisted reproductive techniques and what are their painful aspects?", "answer_source": "NOT_FOUND. The text does not provide information on the specific procedures required daily for assisted reproductive techniques or their painful aspects.", "answer_summary": "NOT_FOUND. The text does not provide information on daily procedures or their painful aspects for assisted reproductive techniques.", "agree": true}, {"question": "7. What are the cultural and social pressures women face related to infertility?", "answer_source": "NOT_FOUND.  The text mentions that the intensity of psychological problems resulting from cultural-social circumstances varies in different societies, but it does not provide specific details about the cultural and social pressures women face related to infertility.", "answer_summary": "NOT_FOUND. The text mentions that cultural and social factors could affect the mental health of women undergoing assisted reproductive treatment for male factor infertility, but it does not provide specific details about the pressures women face.", "agree": false}, {"question": "8. What was the sample size and power level of the study evaluating the effect of assisted reproductive treatments on the mental health of fertile women due to male infertility?", "answer_source": "NOT_FOUND. The text does not provide information on the sample size and power level of the study evaluating the effect of assisted reproductive treatments on the mental health of fertile women due to male infertility.", "answer_summary": "The sample size was 70 fertile women and the text does not provide information about the power level of the study.", "agree": false}, {"question": "9. What were the inclusion criteria for the study on the effect of assisted reproductive treatments on the mental health of fertile women due to male infertility?", "answer_source": "NOT_FOUND.  The text does not provide any information about the inclusion criteria for the study on the effect of assisted reproductive treatments on the mental health of fertile women due to male infertility.", "answer_summary": "The inclusion criteria were being fertile women who underwent assisted reproductive treatment due to male factor infertility.", "agree": false}]}
{"stringID": "pubmed_000040", "qa_pairs": [{"question": "1. In older adults, how does postural sway in the mediolateral direction relate to the risk of falls during different seasons?", "answer_source": "Postural sway in the mediolateral direction in older adults is associated with increased fall risk and rates. Epidemiological studies have shown that vitamin D levels, which are an independent variable associated with postural sway, show seasonal variation with lowest levels recorded towards the end of winter. However, vitamin D", "answer_summary": "NOT_FOUND. The text does not provide information on the relationship between postural sway in the mediolateral direction and the risk of falls during different seasons.", "agree": false}, {"question": "2. What is the association between postural sway and winter fall rates in older adults?", "answer_source": "The text mentions that postural sway is strongly related to other measures of balance in older adults and that lowest levels of serum vitamin D are recorded towards the end of winter, approximately four weeks after the shortest day of the year. However, it does not directly state an association between postural sway and winter", "answer_summary": "NOT_FOUND. The text does not provide information on the association between postural sway and winter fall rates.", "agree": false}, {"question": "3. How do serum vitamin D levels vary in older adults during different seasons?", "answer_source": "The lowest levels of serum vitamin D are recorded towards the end of winter in older adults.", "answer_summary": "Serum vitamin D levels vary seasonally (p < 0.001), peaking in summer.", "agree": false}, {"question": "4. What is the relationship between serum vitamin D levels and postural sway in older adults with suboptimal vitamin D levels?", "answer_source": "Serum vitamin D levels are an independent variable associated with postural sway in older adults with suboptimal levels of vitamin D.", "answer_summary": "NOT_FOUND. The text does not provide information on the relationship between serum vitamin D levels and postural sway in older adults with suboptimal vitamin D levels.", "agree": false}, {"question": "5. How do age-related changes in postural reactions relate to vitamin D status in older adults?", "answer_source": "Age-related changes in postural reactions are related to vitamin D status in older adults through the independent variable association of serum vitamin D levels with postural sway. (Text)", "answer_summary": "NOT_FOUND. The text does not provide information on age-related changes in postural reactions in relation to vitamin D status.", "agree": false}, {"question": "6. In older adults, what is the relationship between vitamin D status and the risk of falls, both inside and outside the home?", "answer_source": "The text states that multivariate analysis reveals serum vitamin D levels as an independent variable associated with postural sway in older adults, and that epidemiological studies have shown that vitamin D levels show seasonal variation with lowest levels recorded towards the end of winter. However, it also mentions that overall", "answer_summary": "NOT_FOUND. The text does not provide information on the relationship between vitamin D status and the risk of falls, both inside and outside the home.", "agree": false}, {"question": "7. How do seasonal changes affect the risk of falls and fractures in older adults?", "answer_source": "Seasonal changes are associated with lower levels of serum vitamin D in older adults, which is an important fall-risk factor. Epidemiological studies have shown that vitamin D levels show seasonal variation, with the lowest levels recorded towards the end of winter. However, vitamin D supplementation did", "answer_summary": "The study found that the incidence of falls and injurious falls was highest at the end of autumn (p = 0.01 and p = 0.02, respectively). However, postural sway, which is a measure of balance and stability, did not vary over the year (p = NOT", "agree": false}, {"question": "8. What are the underlying mechanisms linking age-related changes in postural reactions and vitamin D status?", "answer_source": "NOT_FOUND. The text mentions that balance impairment and postural sway are related, and that serum vitamin D levels are an independent variable associated with postural sway in older adults. It also mentions age-related changes in vitamin D absorption and synthesis. However, it does not", "answer_summary": "NOT_FOUND. The text does not provide information on the underlying mechanisms linking age-related changes in postural reactions and vitamin D status.", "agree": false}]}
{"stringID": "pubmed_000041", "qa_pairs": [{"question": "1. What is the height of Senna alata when it reaches maturity?", "answer_source": "The height of Senna alata when it reaches maturity is 0.15 m.", "answer_summary": "NOT_FOUND. The text does not provide information about the height of Senna alata when it reaches maturity.", "agree": true}, {"question": "2. Which compounds are present in the aqueous leaf extract of Senna alata, and what are their respective percentages (mass/mass)? - saponins, flavonoids, cardiac glycosides, phenolics, alkaloids, cardenolides, dienolides", "answer_source": "NOT_FOUND. The text does not provide information on the specific compounds and their percentages in the aqueous leaf extract of Senna alata.", "answer_summary": "NOT_FOUND. The text only mentions alkaloids from Senna alata leaves and provides information about their potential abortifacient effects. It does not mention the presence or percentages of saponins, flavonoids, cardiac glycosides, phenolics, cardenolides", "agree": false}, {"question": "3. How has the aqueous leaf extract of Senna alata been traditionally used, and what scientific evidence supports this use?", "answer_source": "NOT_FOUND. The text mentions that Senna alata has been used in traditional medicine for managing several diseased conditions, but it does not specifically mention or provide scientific evidence for the use of its aqueous leaf extract.", "answer_summary": "The text mentions that the abortifacient claim of Senna alata (S. alata) has been scientifically validated recently, but the exact traditional use of the aqueous leaf extract is not specified in the text. The text only mentions a study aimed at investigating the pregnancy terminating", "agree": false}, {"question": "4. Where were the plant leaves sourced from for the study?", "answer_source": "NOT_FOUND.  The text does not provide information on where the plant leaves were sourced from for the study.", "answer_summary": "NOT_FOUND. The text does not provide information on where the plant leaves were sourced from.", "agree": true}, {"question": "5. Where was the voucher specimen (FHI 10845) deposited after collection?", "answer_source": "NOT_FOUND.  Question: 6. What is the botanical name of senna alata?  Answer:  Senna alata (Linn.) Roxb. (Leguminosae)  Question: 7. What are the common English names for sen", "answer_summary": "NOT_FOUND. The text does not provide information about the voucher specimen (FHI 10845) being deposited or where it was deposited.", "agree": false}, {"question": "6. Which company provided the assay kits for glucose and cholesterol?", "answer_source": "NOT_FOUND. The text does not mention any company providing assay kits for glucose and cholesterol.", "answer_summary": "NOT_FOUND. The text does not mention any company providing assay kits for glucose and cholesterol.", "agree": true}, {"question": "7. Which company provided the assay kits for progesterone, follicle stimulating hormone, and luteinizing hormone?", "answer_source": "NOT_FOUND. The text does not mention which company provided the assay kits for progesterone, follicle stimulating hormone, and luteinizing hormone.", "answer_summary": "NOT_FOUND. The text does not mention which company provided the assay kits for progesterone, follicle stimulating hormone, and luteinizing hormone.", "agree": true}, {"question": "8. From which companies were the thin layer chromatographic plates and silica gel obtained?", "answer_source": "NOT_FOUND. The text does not provide information about the companies from which the thin layer chromatographic plates and silica gel were obtained.", "answer_summary": "NOT_FOUND. The text does not provide information on where the thin layer chromatographic plates and silica gel were obtained.", "agree": true}]}
{"stringID": "pubmed_000042", "qa_pairs": [{"question": "1. What specific genes, besides androgen receptor, are among the most frequently altered in prostate cancer?", "answer_source": "The most commonly altered genes besides the androgen receptor in prostate cancer are members of the ETS family of transcription factor genes, most commonly ERG (21q22.2).", "answer_summary": "NOT_FOUND. The text only mentions Erg (ETS-related gene) in relation to prostate cancer.", "agree": false}, {"question": "2. Approximately what percentage of surgical cohorts of localized prostate cancer patients have erg gene rearrangements?", "answer_source": "Approximately 40-60% of surgical cohorts of localized prostate cancer patients have erg gene rearrangements.", "answer_summary": "NOT_FOUND. The text does not provide information about the percentage of surgical cohorts of localized prostate cancer patients with erg gene rearrangements. The text only mentions the percentage of patients with erg protein expression in different pathological types of prostate cancer.", "agree": false}, {"question": "3. What have previous studies reported regarding the prognostic significance of erg gene rearrangements in prostate cancer?", "answer_source": "Previous studies have revealed mixed results regarding the prognostic significance of erg gene rearrangements in prostate cancer.  [Reference(s): 19, 22]", "answer_summary": "NOT_FOUND. The text only discusses the investigation of erg protein expression in localized prostate cancer and its correlation with clinical outcome and pathological parameters, but it does not mention previous studies on the prognostic significance of erg gene rearrangements in prostate cancer.", "agree": false}, {"question": "4. How do erg gene rearrangements signify a molecular subtype of prostate cancer?", "answer_source": "Erg gene rearrangements signify a molecular subtype of prostate cancer based on the text. No specific mechanism is mentioned in the text.", "answer_summary": "NOT_FOUND. The text does not provide information on how erg gene rearrangements signify a molecular subtype of prostate cancer.", "agree": false}, {"question": "5. In localized prostate cancer, what is the association between erg protein expression and adverse clinical outcomes?", "answer_source": "NOT_FOUND (Some studies failed to show an association, but a recent report by the group demonstrated an association with lethal disease in patients with unsuspected and advanced/castrate resistant disease.)", "answer_summary": "erg expression was significantly associated with extra-prostatic extension and higher pathological stage and showed a trend toward seminal vesicle invasion. (text)  Therefore, the answer is: erg protein expression is associated with adverse clinical outcomes such as extra-prostatic extension, higher pathological stage", "agree": false}, {"question": "6. How is erg status linked to responsiveness to hormonal therapy and longer progression time to castration resistant disease?", "answer_source": "NOT_FOUND (The text does mention that erg gene rearrangements are linked to a molecular subtype of prostate cancer and that some studies have shown an association of erg expression with lethal disease in patients with advanced or castration resistant disease, but it does not directly state how er", "answer_summary": "NOT_FOUND. The text does not provide information on the link between erg status and responsiveness to hormonal therapy or longer progression time to castration resistant disease.", "agree": false}, {"question": "7. What was the size and mean follow-up duration of the study cohort that underwent retropubic radical prostatectomy?", "answer_source": "NOT_FOUND. The text does not provide information on the size or mean follow-up duration of the study cohort that underwent retropubic radical prostatectomy.", "answer_summary": "NOT_FOUND. The text does not provide information on the size or mean follow-up duration of the study cohort that underwent retropubic radical prostatectomy.", "agree": true}, {"question": "8. How were prostate samples collected and processed for erg protein expression analysis?", "answer_source": "NOT_FOUND. The text does not provide information on how prostate samples were collected and processed for erg protein expression analysis.", "answer_summary": "NOT_FOUND. The text does not provide information on how prostate samples were collected and processed for erg protein expression analysis.", "agree": true}, {"question": "9. What histological diagnoses were verified on the initial slides before erg protein expression analysis?", "answer_source": "NOT_FOUND.  The text does not provide information on the histological diagnoses verified on the initial slides before erg protein expression analysis.", "answer_summary": "The text does not provide information on the histological diagnoses verified on the initial slides before erg protein expression analysis.  Question: 10. What percentage of patients with foamy type PCA had erg expression?  Answer:  The percentage of patients with foamy type PCA who", "agree": false}]}
{"stringID": "pubmed_000043", "qa_pairs": [{"question": "1. What is the location and course of the anterior tibial artery (ASMA) in the distal leg, ankle, and foot, specifically 8-10 cm above the lateral malleolus and 1-2 cm anterior to the edge of the fibula?", "answer_source": "NOT_FOUND. The text mentions the existence of the anterior supramalleolar artery (ASMA) as a major branch of the anterior tibial artery, but it does not provide specific information about its location 8-10 cm above the lateral malleolus and", "answer_summary": "NOT_FOUND.  The text does not provide information about the location and course of the anterior tibial artery (ASMA) specifically 8-10 cm above the lateral malleolus and 1-2 cm anterior to the edge of the fibula.", "agree": false}, {"question": "2. What is the distance between the origin of the anterior tibial artery's anterior supramalleolar branch (ASMA) and the extensor retinaculum?", "answer_source": "NOT_FOUND. The text does not provide the distance between the origin of the anterior supramalleolar branch (ASMA) of the anterior tibial artery and the extensor retinaculum.", "answer_summary": "The mean distance between the origin of the ASMA from the anterior tibial artery to the extensor retinaculum is 2.0 cm.", "agree": true}, {"question": "3. What are the diameters of the anterior tibial artery's anterior supramalleolar branch (ASMA) and its branches?", "answer_source": "NOT_FOUND. The text does not provide information on the diameters of the ASMA or its branches.", "answer_summary": "The diameters of the ASMA's medial branch (d1) and lateral branch (d2) are 1.0 mm and 0.8 mm, respectively. The diameter of the ASMA's artery stem (d3) is 1.1 mm (only in type", "agree": false}, {"question": "4. What is the length of the anterior tibial artery's anterior supramalleolar branch (ASMA)?", "answer_source": "NOT_FOUND. The text does not provide the length of the anterior supramalleolar branch of the anterior tibial artery (ASMA).", "answer_summary": "NOT_FOUND. The text does not provide information on the length of the anterior tibial artery's anterior supramalleolar branch (ASMA) itself. It only provides information on the diameter of the ASMA's stem and its branches, as well as the length of the flaps", "agree": false}, {"question": "5. What collaterals connect the anterior tibial artery's anterior supramalleolar branch (ASMA) with the medial and lateral supramalleolar arteries, and how many perforators are present?", "answer_source": "The text mentions communication between the ASMA and the medial and lateral supramalleolar arteries, but it does not provide an exact number of perforators.  Answer: COMMUNICATION_WITH_MEDIAL_AND_LATERAL_SUPRAMAL", "answer_summary": "NOT_FOUND. The text mentions the origin, course, and diameters of the ASMA and its branches, but it does not provide information about the connections to the medial and lateral supramalleolar arteries or the number of perforators.", "agree": false}]}
{"stringID": "pubmed_000044", "qa_pairs": [{"question": "1. What role does measuring ankle dorsiflexion passive range of motion (df prom) under non-weight-bearing conditions play in physical therapy?", "answer_source": "In physical therapy, measuring ankle df prom under non-wb conditions is used to estimate ankle motion during functional activities and prevent lower extremity injuries.  Question: 2. Why is measuring ankle df prom under weight-bearing conditions more appropriate for estimating the amount of ankle df motion during", "answer_summary": "NOT_FOUND. The text only mentions measuring ankle dorsiflexion passive range of motion under weight-bearing conditions.", "agree": false}, {"question": "2. How may limited ankle df prom with knee extended be related to gastrocnemius tightness and insufficient posterior talar glide?", "answer_source": "Limited ankle dorsiflexion (df) range of motion (ROM) with knee extended may be related to gastrocnemius tightness and insufficient posterior talar glide.", "answer_summary": "NOT_FOUND. The text does not provide information on the possible relationship between limited ankle dorsiflexion with knee extended, gastrocnemius tightness, and insufficient posterior talar glide.", "agree": true}, {"question": "3. Which intervention strategies have been used to increase ankle df prom, specifically gastrocnemius stretching and talocrural joint mobilization?", "answer_source": "Answer:  gastrocnemius stretching and talocrural joint mobilization have been performed as intervention strategies to increase ankle df prom.", "answer_summary": "The intervention strategies used to increase ankle dorsiflexion passive range of motion were gastrocnemius stretching and talocrural joint mobilization.", "agree": false}, {"question": "4. What previous studies have reported regarding the effect of gastrocnemius stretching and talocrural joint mobilization on ankle df prom?", "answer_source": "Previous studies have reported a significant increase in ankle df prom after gastrocnemius stretching and talocrural joint mobilization interventions (references: 3, 8, 9).", "answer_summary": "NOT_FOUND. The text only reports the results of the current study.", "agree": false}, {"question": "5. What is the current state of research on the combined effect of gastrocnemius stretching and joint mobilization on weight-bearing ankle df prom?", "answer_source": "NOT_FOUND. The text mentions that previous studies have reported an increase in ankle df prom after gastrocnemius stretching and talocrural joint mobilization, but it does not specifically mention any research on the combined effect of both interventions on weight-bearing ankle df prom.", "answer_summary": "The text provides evidence of a significant increase in weight-bearing ankle dorsiflexion passive range of motion after the intervention of gastrocnemius stretching and joint mobilization. Therefore, the findings from this study demonstrate the effectiveness of this combination for increasing weight-bearing ankle dorsif", "agree": false}, {"question": "6. Who were the 11 male subjects included in the present study, and what were their limitations in non-weight-bearing ankle df prom with knee extended?", "answer_source": "NOT_FOUND. The text does not provide information about the specific male subjects included in the study and their individual limitations in non-weight-bearing ankle df prom with knee extended.", "answer_summary": "Eleven male subjects with limited ankle dorsiflexion passive range of motion with knee extended participated in the study.", "agree": false}, {"question": "7. Under what conditions was weight-bearing ankle df prom with knee extended measured in the present study?", "answer_source": "NOT_FOUND. The text does not mention when weight-bearing ankle df prom with knee extended was measured in the present study.", "answer_summary": "Weight-bearing ankle dorsiflexion passive range of motion was measured using an inclinometer before and immediately after intervention.", "agree": false}, {"question": "8. How was the force applied to the tested leg during weight-bearing ankle df prom measurements?", "answer_source": "NOT_FOUND. The text does not provide information on how the force was applied during weight-bearing ankle dorsiflexion range of motion measurements.", "answer_summary": "NOT_FOUND. The text does not provide information on how the force was applied during weight-bearing ankle dorsiflexion range of motion measurements.", "agree": true}]}
